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Abstract 
Acetylcholinesterase (AChE, EC. 3.1.1.7)，which is famous for mediating the 
termination of cholinergic neurotransmission, has been proposed to contain 
non-classical functions such as neuritogenesis, cell adhesion and response to various 
insults and physiological stress. In this study, a novel AChE cDNA from Tetraodon 
nigroviridis was cloned for characterization. It encodes 620 amino-acid residues, 
which shows over 60 percent similarity to other vertebrate AChEs. Nine putative 
exons were identified in tnAChE. CCAAT box and CG rich regions were identified 
in the 5' upstream of tnAChE. However, no significant promoter activity was found 
in this region. Multiple sequence alignment of tnAChE against vertebrate AChEs 
reveals a 15 amino acid residues sequence of tnAChE (corresponding to tnAChE 
443-457), which is absent from the mammalian AChEs. This amino acid domain is 
predicted to fold as an a helix located on molecular surface. In an attempt to obtain 
structural information of this enzyme, recombinant tnAChE was expressed in 
bacterial and mammalian Tet-Off inducible system. In bacteria, histidine-maltose 
binding protein (His-MBP) was fused with tnAChE (25-481) at N terminus and the 
recombinant protein was non-functional. TnAChE (1-481) (tnAChEAC) was 
expressed in Tet-Off ready Chinese Hamster Ovary (CHO) cells for inducible protein 
expression. Characterization of tnAChEAC stably-transfected cell clones 
demonstrated a maximal AChE activity, up to 100-fold over the basal, was observed 
xviii 
after 8 hours of induction. TnAChEAC was partially purified by ammonium sulfate 
precipitation and HPLC-gel filtration. The Km of tnAChEAC to acetylthiocholine 
is 2 6 9 ( J M . This study demonstrated tnAChE could be functionally expressed in a 
heterologous eukaryotic expression system, which paves the way for large-scale 















(tnAChEAC )氨基酸殘基在Tet-Off ready中國倉鼠卵巢細胞中表達。在穩定轉 
染的細胞克隆中最高的乙酰膽鹼酯酶活性比基礎值高一百倍。採用硫酸銨和高 
效液相層析法對tnAChEAC進行局部純化。其對硫代乙酰膽鹼的米氏常數爲 
280.9 ^M 0是項硏究顯示了墨綠凹鼻鈍乙酰膽鹼酯酶可在異源的真核生物系統 
中表達並保持活性，這有助於對這酶的進一步大量製造、純化和分析。 
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Chapter 1 Introduction 
7.1 Tetraodon nigroviridis 
1.1.1 Background 
Tetraodon nigroviridis is a spotted green puffer fish with symmetric, round black 
spots on its back and less than 10 centimeters long in capacity. As suggested from 
its genus, it contains four teeth which look a beak. Tetraodon nigroviridis is found 
in Southeast Asia, including Indonesia, Indochina, Malaysia and the Philippines. It 
is not only restrictedly found in the freshwater in nature, for example, rivers, 
mangroves and swaps, but is also found occasionally in the sea, which shows large 
diversity of habitants. Moreover, it is a popular aquarium fish which is easily 
maintained in tap water. It belongs to the family of Tetraodontidae, which is in the 
same family of Takifugu rubripes. Tetraodon nigroviridis diverged from Takifugu 
rubripes 18 - 30 millions years ago, where it diverged from mammal 450 millions 
years ago (Jaillon et al 2004) 
1 
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Figure 1.1 Tetraodon nigroviridis (adopted from http://Cicoda.twbbs.org) 
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1.1.2 Genome Sequencing Project 
Tetaodontidis was kindled much attention in 1968 when R. Hinegardner discovered 
that it has very small genomic size (Brenner et al 1993). The Tetraodon 
nigroviridis genome sequencing project was launched in 1997 by Genoscope (Jaillon 
et al 2004), which is later in collaboration with the Broad of Institute of MIT and 
Harvard. On the other hand, the Takifugu rubripes genome sequencing project was 
launched three years later and the sequences were largely fragmented (Aparicio et al 
2002; Taylor and Semple 2002). According to the first draft of the Tetraodon 
nigroviridis genomic sequence (Jaillon et al 2004)，its genomic size is about 350 
millions base pairs (bp), which is the smallest vertebrate genome known to date. 
The genomic size is one fourth and one eighth of genomic size of zebrafish and 
human respectively. It has 21 chromosomes. The sequencing covers over 90% in 
euchromatin of Tetraodon nigroviridis genome. The GC content is much higher 
than in the genomes of mammals. Like the mammalian genome, the gene rich 
regions are located in the GC rich regions. Transposable elements are rare in the 
Tetraodon nigroviridis genome (Crollius et al 2000; Volff et al. 2003) and are 
concentrated in the heterchromatic region (Dasilva et al 2002). Not more than 
4000 copies of transposable elements were estimated but these elements are in a 
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greater variety than that in mammals. Long interspersed repeats (LINES) occur 
preferentially in GC rich regions and short interspersed repeats (SINES) in AT rich 
regions, which is in contrast to human genome. The current Tetraodon nigroviridis 
genome has 27918 gene models (Jaillon et al 2004), with 6.9 coding exons per gene 
on average, and it is estimated that Tetraodon nigroviridis has between 20000-25000 
protein coding genes. The human and Tetraodon nigroviridis genome have similar 
distribution of intron size, but the intron size of Tetraodon nigroviridis tends to be at 
the lower limit, which is approximately 50-60 bp. However, it was suggested that 
the intron sizes of Tetraodon nigroviridis is different regions from regions. 
1.1.3 Tetraodon nigroviridis as Study Model 
Due to its compact genome, Tetraodon nigroviridis has become an attractive model 
for genomic, paralogy and phylogenetic studies. Furthermore, the promoter studies 
(Chang, et. al,, 2003) and protein molecular characterization (Ikemoto and Park 2005) 
have also been performed in Tetraodon nigroviridis. 
1.1.3.1 Genomic Comparison 
Tetraodon nigroviridis genome has been used to annotate human genome and the 
gene number in human genome was estimated using exon finding by sequence 
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homology (Exofish) (Roest Crollius et al 2000) by the identification of 
evolutionary conserved region (ecore). It is reported that Tetraodon nigroviridis, 
Takifugu rubripes, human and mouse share similar numbers of ecore, and hence, 
suggesting they possess similar number of genes. (Jaillon et al 2004) Roughly 
14500 ecores were novel in the human genome, which lead to the identification of 
904 novel genes in human genome. Among the novel genes, 63% were supported 
by expressed sequence tag (EST) data. 
1.1.3.2 Gene Order and Structural Studies 
Tetraodon nigroviridis has also been used as a model for gene order and gene 
structure studies� G protein-coupled receptors in Tetraodon nigroviridis were 
identified (Metpally and Sowdhamini 2005). Tetraodon nigroviridis G 
protein-coupled receptors are classified into five GRAFS families, which is 
concurrent with human GPCR classification. The gene content around cytochrome 
P450 aromatase (CYP19) was compared among human, Tetraodon nigroviridis and 
Xenopus tropicalis (Castro et al 2005). The analysis revealed that the region retains 
the same gene content since the divergence of Actinopterygii and Tetrapods. 
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1.1.3.3 Genomic Evolution 
There has been controversial argument that ray-finned fish lineage underwent whole 
genome duplication (Williams and Holland 2000; Martin 2001; Wolfe 2001). 
Analysis of Tetraodon nigroviridis and human genome lends some support on the 
proposition of the whole genome duplication. The genome-wide distribution of 
duplicated gene pairs was analyzed (Jaillon et al 2004), 1078 and 995 pairs of 
duplicate genes in Tetraodon nigroviridis and Takifugu rubripes were identified 
respectively. It was suggested that about 75% are 'ancient' duplications that arose 
before the Tetraodon and Takifugu speciation based on frequencies of silent mutation 
between copies. Besides, synteny maps were created among Tetraodon, human and 
mouse. The synteny map typically associates two regions in Tetraodon nigroviridis 
with one region in human. It was demonstrated that Tetraodon nigroviridis genome 
underwent whole genome duplication after its divergence from the mammalian 
lineage. On the other hand, the structure of the ancestral bony vertebrate genome was 
also inferred with reference to Tetraodon nigroviridis and human genome, which 
contained 12 chromosomes. 
1.2 Transcriptional Regulation and Transcription Factor Binding Sites 
6 
Prediction 
1.2.1 Transcriptional Regulation 
Transcriptional regulation is a complex process which combines chromatin 
remodeling, promoters, activators, repressors, etc. 
1.2.1.1 Chromatin Remodeling 
DNA is incorporated into a lOnm-diameter nucleosomal fiber with each nucleosome 
containing a core histone octamer and a linker histone HI or H5 (Ausio et al. 1989; 
Grunstein 1990; Grunstein 1990). It is necessary for transcriptional factors to gain 
localized access to chromatin before transcription, which result in recruiting 
acetylases or other chromatin-remodeling. Dynamic role of chromatin in gene 
regulation was found in S. cerevsiae. Nucleosome depletion in vivo has been found 
to result in transcriptional activation in a general manner (Saunders et al 1990) 
Independent genetic studies in yeast have revealed that the N termini of hi stones H3 
and H4 are important for transcriptional activation of a subset of genes (Grunstein 
1990; Grunstein 1990). Besides, a correlation has been established between 
transcriptional active genes and acetylation of amino-terminal lysine residues in 
histone H4 (Hebbes et al. 1988; Paranjape et al 1994). The remodeling of 
chromatin was found to be ATP-dependent, and the remodeling complexes contain a 
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subunit with conserved ATPase motif. It disrupts the characteristic 10-bp period 
repeat of DNasel cleavage within a positioned nucleosome in vitro and enhances 
access of transcriptional factors to the DNA. Acetylation and deacetylation of 
hi stone tails represents a major regulatory mechanism during gene activation and 
repression. Hi stone hyperacetylation has been associated with hi stone deposition 
during replication and repair, and with transcriptional active chromatin. Active 
transcribed regions are associated with hyperacetylation, whereas deacetylation is 
associated with repression. In mammalian somatic cells, CpG dinucleotides found 
are in tissue-specific genes which often contain methylated cytosine base when 
transcriptional inactive (Paranjape et al 1994; Bhattacharya et al 1999; 
Ramchandani et al 1999). Transcriptional silencing can be obtained by silencers. 
Silencers are DNA elements that modulate transcription by influencing chromatin 
structure (Brand et al 1985; Laurenson and Rine 1992; Ogboume and Antalis 1998). 
1.2.1.2 Locus Control Regions (LCR) and Boundary Elements 
LCRs are regulatory regions that modulate transcription by influencing chromatin 
structure through an extend end DNA region and appear to induce and maintain 
accessibility of that region to transcriptional factors as measured by nuclease 
sensitivity (Fraser and Grosveld 1998; Grosveld 1999). Insulator (Geyer 1997; Bell 
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and Felsenfeld 1999) and matrix attachment regions (Cuvier et al 1998; Hart and 
Laemmli 1998) are considered to be involved in prevention of transcription at 
adjacent loci, and they are known as boundary elements. They have been identified 
in Drosophila, chicken, mammalian cells, etc. Most boundary elements were 
identified on the basis of their location. The boundary elements in general appear to 
be in the vicinity of junctions between decondensed and condensed chromatin. 
1.2.1.3 Promoter Structure 
Promoters in eukaryotes are different from prokaryotes in which operons are rare. 
The organization of promoters is less regular than that of coding sequence and no 
consistent sequence motifs exists for promoter of protein coding genes. In general, 
promoters are identified by two features. They are basal promoter and a collection 
of diverse transcription factor binding sites (Latchman 1998; Kuras and Struhl 1999; 
Lee et al 2000; Lemon and Tjian 2000). It was reported that the basal promoter 
was not a common point of regulation, though it is necessary for transcription. 
Different basal promoter sequences have been reported. Many genes have the 
critical TATA box. TATA box usually locates about 23-30 bp 5' of the transcription 
start site. However, some genes lack a TATA box, but they have an initiator element 
spanning the transcriptional start site. Some promoters contain neither a TATA box 
9 
nor an initiator element, but contain several transcription initiation start sites, a high 
CG content and multiple binding sites for mammalian transcription factor Spl (Ohler 
and Niemann 2001). A gene may have a combination of different types of promoter 
(Goodyer et al 2001). Genes with TATA-less basal promoters may generally be 
transcribed constitutively at relatively low level (Pugh and Gilmour 2001), but the 
functional consequences of different basal promoter structure are not clear. 
1.2.1.4 Transcriptional Machinery Assembly 
Eukaryotic genes that encode proteins are mediated by the RNA polymerase II 
holoenzyme complex on basal promoter (Lee and Young 1998; Reinberg et al 1998; 
Irvin and Pugh 2006). It is composed of 10 to 12 proteins, for example, RNA 
polymerase II (PolII), TFIID, TFIIE, etc (Reinberg et al 1998; Lee et al 2000). 
PolII is a large multi-subunit enzyme, with heptapeptide repeat constituting the C 
terminus of the largest subunit. The complex is nucleated by the binding of 
TATA-binding protein (TBP) to the TATA box (or basal promoter) with an aided by 
TFIIA or TFIIB to cause a conformational change in DNA. A complex of TFIIF in 
association with PolII is recruited afterwards, followed by sequential binding of 
TFIIE and TFIffl. 
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1.2.2 Transcription Factors and Their Binding Sites 
Even when the local chromatin is decondensed, a basal promoter initiates 
transcription at a very low rate (Jackson-Fisher et al 1999). Transcriptional factors, 
which bind to basal promoter regions, are ubiquitously expressed and provide little 
regulatory specificity (Lee and Young 1998; Lemon and Tjian 2000). Transcriptional 
factors belong to gene families (Latchman 1998, Locker 2001) and they can be 
activators or repressors. They contain a combination of several distinct functional 
domains, including DNA-binding domains (Wray et al 2003), protein-protein 
interaction domains, domains that act as intracellular trafficking signal (Abu-Shaar et 
al. 1999) and ligand-binding domains. Binding sites commonly have a minority of 
nucleotides within a promoter region, and are often interspersed with regions that 
contain no binding site (Wray et al. 2003). The binding sites are usually short, with 
4 - 6 bp for a typical binding site. The position of transcription factor binding site 
relative to the transcription unit also differs enormously among genes and not only 
restricted to 5' of transcription start site (Kammandel et al 1999). 
1.2.3 Transcription Factor Binding Site Prediction 
Studies show that transcription plays an important role in regulation of gene 
expression. Most of the transcriptional regulation is mediated by protein-DNA 
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interactions. These interactions form a complex network. The reliable prediction 
of cis-regulatory elements and the prediction of individual transcription factor 
binding sites have proven to be a challenge task, though a wide range of 
computational tools are available. 
There are many algorithms to predict transcription factor binding sites. Current 
predictive tools have been designed on the basis of sharing similar characteristics of 
transcription factor binding sites. Protein usually interacts with a short sequence of 
DNA, which is generally less than 20 bp. However the binding sites tend to be 
degenerated (Mirny and Gelfand 2002). The binding profile is summarized in 
binding matrix. Binding matrix for a transcription factor is generated by aligning 
identified sites, followed by counting the frequency of each DNA base at each 
position of the alignment. Several hundred matrices for specific transcription 
factors are available through the database of TRANSFAC and JASPAR (Wingender 
et al 1996; Sandelin et al. 2004). Nevertheless, the available binding site matrices 
for many transcription factors are small and not specific enough to enable a reliable 
prediction of sites in long sequences without any additional information (Rahmann et 
al. 2003). For example, in large genomes, such as that of human, thousands of 
potential transcription factor binding sites are expected to be found by chance. 
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In order to reduce false positives, which are the artificially predicted transcription 
factor binding sites, methods with other criteria, such as conservation of sites across 
different species, clustering of binding sites near co-regulatory regions and 
enrichment of specific sites near co-regulated genes, are employed (Vavouri and 
Elgar 2005). 
Conserved non-coding sequences are suggested to be good candidates for 
transcription regulatory elements (Aparicio et al 1995; Gottgens et al 2000; 
Hardison 2000; Loots et al 2000; Lattice et al 2003; Nobrega et al 2003; Woolfe et 
al. 2005). Several highly conserved non-coding sequences were identified in 
vertebrate genomes. They are more conserved than protein-coding exons in many 
cases (Bejerano et al. 2004; Bofifelli et al 2004; Ovcharenko et al. 2004; Sandelin et 
al. 2004; Dermitzakis et al 2005; Woolfe et al 2005). It was confirmed that 
individual transcription factor binding sites are more conserved than their 
surrounding sequences (Moses et al 2003). The use of evolutionary conservation 
of sequences in identifying putative regulatory element can be useful in narrowing 
the search space and increase the significance of some sites. However, it may fail 
to detect the genuine regulatory sites. Recent studies on regulatory elements in 
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mammals and Drosophila have shown that between one- and two-thirds of identified 
transcription factor binding sites are not conserved even between relatively closely 
related species (Dermitzakis and Clark 2002; Costas et al 2003; Emberly et al 2003). 
Clustering of sites for relevant transcription factors in small regions of metazoan 
genomes is considered as a reliable indicator of regulatory function and has been 
widely used for computational prediction of regulatory elements (Freeh et al 1998; 
Kel et al 1999; Krivan and Wasserman 2001; Berman et al 2002; Lifanov et al. 
2003; Markstein et al 2004; Sandelin and Wasserman 2005) When regulatory 
elements cannot be identified by sequence similarity, clustered binding sites allow 
the prediction of likely candidates (Erives and Levine 2004). Four neurogenic 
regulatory elements in Drosophila have revealed that not only they contain sites for 
similar sets of transcription factors but also they have a similar arrangement (Erives 
and Levine 2004; Markstein et al. 2004) 
Computational prediction is often limited to identifying enriched motifs in sets of 
co-expressed gene (Tronche et al 1997; Tavazoie et al. 1999; Pilpel et al 2001). 
However, these approaches will miss regulatory elements in less obvious locations 
such as in introns and far upstream of downstream of genes. Genome-wide 
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chromatin immunoprecipitation experiments (Ren et al 2000) have reported that a 
significant proportion of transcription factor binding sites do not lie in regions 
immediately upstream of known protein-coding genes (Cawley et al 2004; Impey et 
al 2004; Matyash et al 2004; Testa et al 2005). In addition, comparative 
genomics has revealed that many regulatory elements, which are involved in early 
vertebrate development, lie far away from the genes that are thought to regulate 
(Lettice et al 2003; Nobrega et al 2003; Woolfe et al. 2005) 
1.3 Acetylcholinesterase 
1.3.1 Background 
Acetylcholinesterase (AChE) is found from invertebrates to vertebrates (Taylor et al 
1974; Lee et al 2006) and expresses in various tissues like brain, muscle, liver, eye, 
erythrocytes, etc (Schegg et al 1986; Munoz-Delgado and Vidal 1987; Fuentes and 
Inestrosa 1988; Salceda and Martinez 1992; Liao et al 1994; Gomez et al. 1999). It 
is also expressed in plants (Li and Han 2002; Muralidharan et al 2005; Sagane et al 
2005). It was first discovered following the identification of cholinergic 
neurotransmitter acetylcholine. AChE hydrolyses acetylcholine in synapse and 
terminates the cholinergic neurotransmission at extremely fast rate, which is near 
diffusion rate. Large amount of AChE was purified from Torpedo California, due 
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to its AChE-rich electric organ. The first crystal structure of AChE was obtained in 
1993 from torpedo (Sussman et al 1993). The active site of AChE was determined 
by site-direct mutation (Shafferman et al 1992) and found to be at the bottom of a 
long deep narrow gorge. After resolution of AChE structures from different species, 
AChE is demonstrated to share fundamental similarity among different species. 
Apart from the extraction from tissues, recombinant AChE was also purified from 
different expression systems, including bacteria, yeast, insect cells, etc (Sussman et 
al. 1993; Heim et al 1998; Bertrand et al 2001). It was shown that the expression 
of AChE is temperature dependent for correct protein folding (Simon and Massoulie 
1997). Recombinant AChE from electrophorus and torpedo are inactive at 37°C 
and partially active at 28°C. In some case, refolding of denatured AChE is 
necessary in order to obtain active AChE, especially in bacterial expression systems 
(Koke et al 1991; Fischer et al 1993; Sussman et al. 1993). AChE has been 
characterized in neuromuscular junction (Guerra et al 2005; Krejci et al 2006). 
Different forms of AChE (G4 to A12) were found in neuromuscular junction and 
AChE was localized at the end-plates. 
1.3.2 Regulation of AChE 
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AChE is regulated at different levels, including transcriptional, post-transcriptional 
and post-translation level, which gives rise to its complexity. 
1.3.2.1 Transcriptional Level 
Single AChE gene is found in vertebrates (Li et al 1991; Cousin et al 1998; 
Bertrand et al 2001), whereas multiple copies of AChE are found in invertebrates 
(Hall and Spierer 1986; Johnson et al 1988; Hall and Malcolm 1991; Arpagaus et al 
1994; Anthony et al 1995; Chen et al 2001). More than one copies of AChE genes 
were observed in C. elegans (Johnson et al 1988; Arpagaus et al 1994), while only 
one copy of AChE was reported in Drosophila (Hall and Spierer 1986). 
Promoter of AChE gene was identified in various species, including human, mouse, 
torpedo and C. elegans (Ekstrom et al 1993; Taylor et al 1993; Arpagaus et al. 1994; 
Atanasova et al 1999). Evolutionarily conserved promoters were reported by 
analysis the homologues of AChE gene in mouse and human (Meshorer et al. 2004). 
Enhancers were found not only in distal domain of the promoter of AChE, but also in 
the first intron of AChE (Ben Aziz-Aloya et al 1993; Chan et al 1999; Angus et al 
2001). 
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TATA box is not commonly found in AChE promoter region. No TATA box and 
CAAT box was found at the consensus distance from the transcription start site in C. 
elegans and human (Culetto et al 1999). Nevertheless, TATA box was found in 
zebrafish (Bertrand et al 2001). Human AChE promoter is composed of consensus 
motif of MyoD, E-box, Spl, ERGl and AP-2 (Ben Aziz-Aloya et al 1993). The 
GC rich region with overlapping SPl and Egrl is essential for mousQ AChE promoter 
(Mutero et al 1995). The Spl and Egrl compete with each other for DNA binding. 
An increase in Egr-l binding causes a decrease in AChE expression. Both the 
TATA box and TATA-less promoter are found in mouse AChE (Mutero et al 1995; 
Atanasova et al 1999). On the other hand, cAMP-dependent pathway activates 
promoter of human AChE in cultured NG108-15 neuroblastoma cells (Wan et al 
2000). In human brain, AChE is regulated by c-fos and HNFSp under various stress 
conditions (Kaufer et al 1998; Meshorer et al 2002; Perry et al 2002). AChE 
promoter contains a proximal 600 bp (Ben Aziz-Aloya et al. 1993; Getman et al 
1995) including AMLl/Runxl (Perry et al 2002). It also consists of a distal 
enhancer domain, which is located 17kb 5' upstream of transcription start site 
including functional binding factors for osteogenic factor, 17|3-estradiol and 
1,25-dihydroxyvitamin D2, HNFSp, NFKB, c-fos and C/EBP (Perry et al 2002) and 
containing consensus binding site of AP2, SPl, N F K B and GATAl in the first intron. 
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1.3.2.2Post-transcriptional Level 
AChE messenger RNA (mRNA) is transcribed through alternative splicing of mRNA 
(Taylor et al 1993). There are mainly three types of mature AChE mRNA found in 
mammals, AChE-R^ AChE-E and AChE-S. AChE-E and AChE-S mRNA encode 
AChE-H and AChE-T forms of protein. Only the AChE-S mRNA form is reported 
in zebrafish (Bertrand et al 2001). Different forms of AChE mRNA show distinct 
tissue specificity. All three mRNA share the same exons from exon 2 to exon 4, 
where exon 2 encodes the signaling peptide sequence which is removed to form the 
mature protein. The core catalytic domain is encoded by exon 3 and exon 4. 
AChE-K mRNA is the readthrough form of AChE. It is observed in embryonic, 
tumor cell and were inducible by psychological, chemical and physical stress 
(Nijholt et al 2004; Meshorer et al 2005; Perrier et al 2005). AChE-E mRNA is 
expressed in erythrocyte whereas AChE-S mRNA is mainly expressed in brain and 
muscle. Glial cells release AChE as response to hypoxic damage, and it was found 
that AChE mRNA expression was changed from S form to R form. Hence, 
alternative splicing of AChE mRNA may partially be induced by the stress response 
(Pick et al 2004; Pick et al. 2004). 
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1.3.2.3 Post-translational Level 
Besides the regulations mentioned, regulation of AChE proteins is also modified 
through allosteric interaction, glycosylation, phosphorylation, etc. It was reported 
that correct folding is a limiting factor of obtaining functional AChE (Morel and 
Massoulie 2000). 
1.3.2.3.1 Oligomerization 
AChE proteins are mainly classified to AChE-T and AChE-H, while T and H 
represent tail and hydrophobic respectively. AChE-T and AChE-H are encoded by 
AChE-S mRNA and AChE-E mRNA respectively. In mammals, AChE protein can 
be monomeric, dimeric, tetrameric, GPI-anchored, or collagen-anchored, 
collagen-like tail ColQ (Ohno et al 1998) in neuromuscular junction and PRIMA in 
brain (Perrier et al. 2002; Perrier et al. 2003). ColQ is demonstrated to play an 
important role in AChE localization. Humans with certain specific mutations and 
deletions in their ColQ molecules can assemble normal A12 collagen-tailed AChE, 
but have virtually no AChE localized at sites of nerve-muscle contact (Donger et al 
1998; Ohno et al 1998; Ohno et al 2000). ColQ null mouse completely lacks 
AChE at neuromuscular junction (Feng et al 1999) indicating that ColQ is a 
targeting subunit responsible for localization and attachment of AChE to the 
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neuromuscular synapse. GPI-anchored form of AChE is dimerized through cysteine 
at carboxyl-terminus (C-terminus). They share the same core catalytic domain, but 
variable C-terminus. Different molecular forms of AChE distribute in different 
tissues, for example, all forms are observed in neuromuscular junction and brain 
(Liao et al 1994; Saez-Valero et al. 1999) where GPI-anchoring AChE is found in 
erythrocytes. GPI-anchor directs AChE to membrane attachment and dynamics 
(Nalivaeva and Turner 2001). AChE on erythrocyte cell surface contributes to the 
blood group antigen properties, the C artwright (Yt) antigens (Telen 1995). 
1.3.2.3.2 Glycosylation 
Various amounts of carbohydrate residues were shown attached to AChE molecules 
through the asparagines residues (Liao et al 1992). The dimeric AChE from 
erythrocyte membranes is more heavily glycosylated than tetrameric brain AChE. 
The degree of glycosylation of same molecular form of AChE is different among 
species. Different forms of AChE may lead to different glycosylation patterns. 
Glycosylation is important to the circulatory life-time of AChE in the blood stream. 
Besides, it was reported that the number of N-glycosylation sites plays a role in the 
circulatory life-time of the enzyme. Proper glycosylation of AChE is also important 
to normal brain function by comparison of the glycosylation patterns of AChE in the 
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brain and cerebrospinal fluid of Alzheimer's disease (AD) patients and normal 
people (Saez-Valero et al 1999; Saez-Valero et al 2000; Saez-Valero et al 2000). 
The distribution and glycosylation of AChE forms from the intracellular membranes 
have also been reported differently when muscles of normal and Lama2 (dy) 
dystrophic mice were compared (Cabezas-Herrera et al 1997). 
1.3.2.3.3 Phosphorylation 
Experiments demonstrate that AChE possesses several consensus sites for 
phosphorylation (Soreq et al 1991). It was demonstrated that after alkaline 
phosphatase treatment and electrophoresis under denaturing conditions, a fraction of 
AChE from different mammalian sources migrates faster than non-treated enzyme. 
It indicated that AChE might be phosphorylated in vivo (Grifman et al 1997). On 
the other hand, protein kinase A phosphorylation of AChE was shown to compensate 
the suppression of AChE activity by a variety of inhibitors. Thus, it was suggested 
that phosphorylation of AChE may play a role in protective rapid feedback 
mechanism against impairments of cholinergic neurotransmission (Soreq et al 1991; 
Grisam et al 1999). 
1.3.3 Functions of AChE 
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1.3.3.1 Hydrolysis Acetylcholine 
AChE is well-known for its hydrolysis of acetylcholine as in Figure 1.2 
AChE 
acetylcholine acetate 
^ ^ OH 
choline ^ ^ � 
Acetyl-AChE 
Figure 1.2 Schematic diagram showing hydrolysis of acetylcholine by AChE 
AChE is preferable to acetylcholine from butrylcholine, and it is inhibited by various 
compounds, for example, BW284C51, huperzine, etc. 
1.3.3.2 Embryonic Development 
AChE is required for neural and muscular in zebrafish embryo (Behra et al 2002). 
AChE mutated zebrafish embryo was initially motile, but subsequently became 
paralyzed. Muscle fiber formation and innervations were defected. The defect 
was suggested to be mediated by activation of nicotinic acetylcholine receptor. 
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1.3.3.3 Haemotopotesis and Thrombopsiesis 
AChE was found in blood-cell progenitors (Paoletti et al 1992; Lev-Lehman et al 
1997). Transcriptional activation of AChE was shown during haemaglutinin 
induced lymphocyte activation (Kawashima and Fujii, 2000). Transient 
suppression and subsequent overproduction of AChE after treatment with antisense 
oligodeoxynucleotides induced myeloid proliferation in mouse bone-marrow-cell 
cultures (Soreq etal 1994). 
1.3.3.4 Neurit ogensis 
Exogenous purified AChE promoted neurite growth from chick nerve cells in culture 
and this effect was not abolished by AChE active-site inhibitors (Soreq et al 1994). 
Transfection with AChE showed neuritogenic activity of enzyme in neuroblastoma 
cells (Koenigsberger et al 1997). Expression of AChE-S in Xenopus motor 
neurons showed enhanced neurite growth rate. 
1.3.3.5 Amyloid Fiber Assembly 
AChE was demonstrated to interact with amyloid (3 and promote amyloid fibril 
formation. The interacting site was found to be close to the peripheral anionic 
binding site of the enzyme (De Ferrari et al. 2001) 
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Apoptosis 
AChE was reported to be associated with apoptosis in various cell types (Zhang et al. 
2002) and later studies showed that over expression of AChE prevented caspase-9 
activation, decreased cell viability, caused nuclear condensation and cleaves 
poly(adenosine diphosphate-ribose) polymerase.(Park et al 2004) It was further 
demonstrated that interaction between apoptotic protease-activating factor-1 and 
cytochrome C was blocked by silencing AChE expression. 
1.3.4 AChE and Alzheimer's Disease 
AD is a neurodegenerative disease and is the most common form of dementia 
(Galasko et al 1994; Katzman et al 1994). It shows progressive deterioration of 
cognitive function and severe change in personality (Coyle et al 1983; Kaufmann et 
al. 1998). Neuronal and synaptic connection is lost in the AD patients. AD is 
characterized by amyloid containing plaque and neurofibrillary tangle (Ko et al. 
1999). 
Amyloid plaques are clumps of protein that accumulate outside the brain's nerve 
cells (Price et al 1986; Terry 1986). The amyloid deposit mainly consists of 
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amyloid P proteins (Ap). Ap are 4kDa proteins, which is derived from amyloid 
precursor protein (APP) through proteolytic processing (Goldgaber et al. 1987; Kang 
et al 1987; Tanzi et al 1987). Various forms of Ap have been reported, including 
amino-terminally (N-terminally) and C-terminally truncated amyloid P peptides , for 
example Ap40 and Ap42(Masters et al 1985; Kang et al 1987; Joachim et al 1988; 
Prelli et al 1988; Mori et al 1992; Perry et al 1992; Miller et al 1993; Nordstedt et 
al 1994). AP42 is more prone to fibril formation than Ap40. Missense mutations 
have been reported as a genetic factor of AD (Chartier-Harlin et al 1991; Goate et al. 
1991; Hardy and Higgins 1992). A|342 is a primary component of amyloid plaques 
in both familial and sporadic AD (Selkoe 2001; Tanzi and Bertram 2001; Chang and 
Suh 2005). 
Tangles are twisted strands of tau protein that form inside neuronal cells. 
Neurofibrillary tangle is formed by hyperphosphorylation of tau protein. Tau is a 
microtubule-associated protein, primarily located in the neuronal axons. Tau 
promotes microtubule assembly and stability through binding to tubulin in the axonal 
microtubules (Goedert et al 1989; Buee et al 2000). It is important for axonal 
function and transport. Besides, tau is a phosphoprotein (Buee et al 2000; Iqbal et 
al. 2002). The tangles in AD are made up of an abnormally hyperphosphorylated 
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from of tau (Grundke-Iqbal et al 1986). Because of the hyperphosphorylation, tau 
also loses its ability to bind to the microtubules and to stimulate their assembly. 
1.3.4.1 Treatment for AD Patients 
Currently, AChE inhibitors are available drugs for AD treatment. However, the 
mechanism of AChE inhibitors towards AD is still not clear. It was proposed that 
AChE inhibitors possibly induce AChE overproduction, which consequently 
switches AChE alternative splicing from T form to R form, causing a decrease of 
AChE at the synapse. AChE was also suggested to take part in the amyloid 
metabolism. Besides promoting amyloid fibril formation as mentioned above, it 
was reported that AChE inhibitors cause a decrease in AD AMI 0 expression in 
human neuroblastoma cells (SH-SY5Y) which produce more sAPPa released in the 
culture medium (Zimmermann et al 2004). 
An increase in releasing AChE is a critical molecular signal in neurodegeneration 
(Greenfield and Vaux 2002; Toiber and Soreq 2005). AChE was found in 
neurofibrillary tangles and amyloid-positive vessels (Coleman et al 1992). 
Different glycosylated isoforms of AChE were reported in cerebrospinal fluid in APP 
wild type transgenic mice before amyloid plaque deposition (Saez-Valero et al 2003). 
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A similar phenomenon was also observed in AD patients. Hence, glycosylated 
AChE was suggested to be a biomarker for AD. In cerebral cortex of rats, the 
age-related decline of total AChE was found to be accompanied by decrease in 
G4/G1 ratio, due to decrease in membrane-bound AChE (Bisso et al 1991). It was 
also found an increase in proportion of G1 and G2 in cortex and cerebrospinal fluid 
of AD patients (Saez-Valero etal 2000). 
1.4 Inducible Cell Expression Systems 
Tet-On and Tet-Off systems are tetracycline (Tet) regulated cell expression systems 
which are being exploited to express the toxic or difficult expressed proteins in 
mammalian cells (Corbel and Rossi 2002; Johansen et al 2002; Mizuguchi and 
Hayakawa 2002). The Tet regulated system is originated from E. coli (Okamoto 
and Mizuno 1964; Hoekstra et al 1973; Foster 1977; Kleckner et al 1978). In E. 
coli, the tetracycline-resistance operon on the TnlO with Tet repressor protein (TetR) 
blocks transcription of target genes by binding to the Tet operator sequences (tetO) in 
the absence of tetracycline. Tet-systems employ tetO and tetR to regulate protein 
expression level in cultured cells. 
In the Tet-Off System, TetR is fused to the C-terminal of the Herpes simplex virus 
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VP 16 activation domain (Triezenberg et al 1988). The resulting hybrid protein 
(tTA) is encoded by the pTet-Off regulator plasmid. On the other hand, the 
regulatory protein of Tet-On system is based on a "reverse" Tet repressor (rTetR) 
(Hillen and Berens 1994; Gossen et al 1995). The resulting protein, itTA (reverse 
tTA), is encoded by the pTet-On regulator plasmid. A response plasmid which 
expresses target gene is under control of the tetracycline-response element (TRE). 
Gene X is only expressed upon binding of the tTA or rtTA protein to the TRE 
(Figure 1.3). In the Tet-Off System, tTA binds the TRE and activates transcription in 
the absence of tetracylcine or doxycycline (Dox). In the Tet-On system, rtTA binds 
the TRE and activates transcription in the presence of Dox. In both Tet-On and 
Tet-Off systems, transcription is turned on or off in response to Dox in a precise and 
dose-dependent manner. 
The Tet-Off and Tet-On systems have several advantages over other regulated gene 
expression systems that function in mammalian cells. Firstly, the regulation is tight 
and background or leaky expression of target gene in the absence of induction is low. 
Secondly, when introduced into mammalian cells, the prokaryotic regulatory proteins 
(TetR or rTetR, the prokaryotic precursor to tTA and rtTA) act very specifically on 
their target sequences, presumably because these regulatory DNA sequences are 
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nonexistent in eukaryotic genomes (Making et al 1999). Thirdly, expression of 
Gene X is controlled by activation, rather than repression, which is more difficult to 
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Figure 1.3 Schematic diagram of 
A. Tet-Off system and 
B. Tet-On system 
(adopted from Tet-Off and Tet-On Gene Expression System User Manual) 
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1.5 Objectives 
The AChE promoter and its regulatory elements have been characterized in human, 
mouse, rat, Drosophih, C. elegans, torpedo and there is little investigation in teleost. 
Though the promoter has been investigated in zebrafish AChE, it is not sufficient to 
generalize the regulatory elements of AChE transcription in teleost, as well as 
comparison between teleost and mammalian AChE. As Tetraodon nigroviridis has 
a compact genome, its intergenomic region is shorter than those found in 
mammalians. This suggests that the regulatory elements in the promoter region 
would be more condensed and clustered together. It would serve as an ideal model 
to find functional regulatory elements for transcription and elucidate the 
transcriptional regulation for AChE in teleost, as well as providing evolutionary 
insight for the gene regulation of AChE. In order to achieve the goal, the promoter 
region of Tetraodon nigroviridis AChE (^nAChE) was cloned from genomic DNA 
and was analyzed in silico and in vitro. The full coding cDNA of tnAChE was also 
cloned and expressed in different expression systems to obtain enzymatically active 
AChE for further structural analysis. 
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Chapter 2 Materials and Methods 
2.1 Materials 
Restriction enzymes and DNA modifying enzymes were obtained from New England 
BioLab. Other materials not listed below were purchased from Sigma, Bio-Rad, or 
Amersham. 
Trizol� ,TA cloning kit, pjx DNA polymerase, high fidelity Taq DNA polymerase, RNA 
supercriptin, Ikb Plus DNA ladder and X-gal were purchased from Invitrogen. The 
pGL3 series, pTRE2hygo and pEFP-Nl vectors were from BD Clontech. Luciferase 
assay system was purchased from Promega. Gel extraction kit was from Qiaquick. 
Desalted and lyophilized primers were synthesized by Invitrogen. DNA sequencing 
service was from Tech Dragon Ltd, Hong Kong. 
Acrylamide, bis-acrylamide, mini-Protean n electrophoretic system, ammonium 
presulfate, N', N,, N，，N'-termethylethylenediamine (TEMED), sodium dodecyl sulfate 
(SDS) were purchased from Bio-Rad. Superdex 75 10/300 GL was from Amersham. 
Benchmark prestain protein markers, anti-His G antibodies, dimethyl sulfoxide (DMSO) 
were from Invitrogen. Fuji super rx x-ray film was purchased from Fuji Medical 
product Ltd. Tris base, glycerol, glycine, CEL western blotting detection reagent, and 
isopropyl thiogalactoside (IPTG) were obtained from Amersham. His-bind resin was 
from Novagen. Mouse anti-GAPDH antibody was from ABCam. Mouse anti-rat AChE 
antibody was from Transduction Lab. Imidazole, dithiothretiol (DTT), sodium chloride 
(NaCl), Tritron-XlOO, 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), acetylthiocholine, 
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hyperzine and tetraisopropylpyrophosphoramide (iso-OPMA) and Immobilon-P 
membrane were obtained from Sigma. 
The cell lines SH-SY5Y and C2C12 were purchased from American Type Culture 
Collections. Tet-Off ready Chinese Hamster Ovary (Tet-Off CHO) cells were BD 
Clontech. D-MEM/F12, D-MEM, MEMa powders, fetal bovine serum (FBS), 
hygromycin B, trypsin, penicillin, streptomycin and lipofectamine were obtained from 
Invitrogen. Doxycyline，Tet-system approved FBS was obtained from BD Clontech. 
Cell culture dishes and plates were from Coming. Tetraodon nigroviridis was bought 
from local aquarium market. 
2.2 Methods 
2.2.1 Primer Design 
Primers for protein expression were based on Genebank accession number: AY733039， 
which primers for promoter analysis were designed according to Tetraodon nigroviridis 
whole genome sequence SCAF11900 from ensembl database. 
2.2.2 Cell Culture 
Human neuroblastoma cells (SH-SY5Y) were grown in DMEM/F12 containing 10% 
FBS, 100 units/ml penicillin and 100 jag/ml streptomycin at 37�C in water-saturated 
atmosphere of 95% air and 5% CO2 
Mouse muscle C2C12 cells was cultured in DMEM supplemented with 20% FBS, 100 
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units/ml penicillin and 100 (xg/ml streptomycin at 37�C in water-saturated atmosphere of 
95% air and 5% CO2. 
Tet-Off CHO cells were maintained in MEMa containing 100 units/ml penicillin and 
100 |Lig/ml streptomycin, 100 |xg/ml G418 and 5% Tet-system approved FBS in water-
saturated atmosphere of 95% air and 5% CO2. 
2.2.3 Transformation 
An amount of 2 \i\ of ligation products or 50 ng DNA construct was mixed with 100 \i\ 
competent cell (E. coli. strain TOPOlO). After incubation on ice for 30 minutes, 
followed by 30 seconds heat shock at 42�C and two minutes on ice, 300 jil Luria-Bertani 
medium (LB) (1% (w/v) tryptone, 0.5% (w/v) yeast extract and 10% NaCl) was added 
and inoculated at 37�C for one hour. The cells were then spread on 100 |ag/ml ampicillin 
selective LB agar plate and incubated at 37�C for 18 hours. 
2.2.4 Plasmids Preparation 
Plasmids were prepared using the alkaline method. In brief, colonies were picked and 
inoculated in 3 ml LB with 100 |xg/ml ampicillin at 37�C for 18 hours. Cells were 
collected by centrifugation at 2 5 1 4 , 0 0 0 rpm for 2 minutes and then resuspended in 
100 (xl lysis buffer I (0.1 M Tris-Cl, pH 8.0, 50 mM ethylenediaminetetraacetic acid 
(EDTA), 20% glucose)，mixed with 200 \i\ lysis buffer n (0.2 N sodium hydroxide 
(NaOH), 1% SDS) and precipitated in 150 lysis buffer EI (3 M potassium phosphate, 0.5 
M sodium acetate). Clear supernatant was obtained by centrifUged at 25�C, 14,000 rpm 
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for 10 minutes. RNase A was added to 100 fxg/ml at the final concentration and 
incubated at 37�C for 2 hours. An equal volume of phenol-chloroform was added, 
mixed by vortex and centrifuged at 25°C, 14,000 rpm for 5 minutes. Plasmid DNA was 
precipitated from the aqueous solution with 2 volume of 100% ethanol and collected by 
centrifugation at 25�C, 14,000 rpm for 15 minutes. After being air dried, plasmid DNA 
was dissolved in autoclaved NANOpure water. 
2.2.5 Plasmids Screening 
Positive clones were identified by restricted digestion. An aliquot of 1 |ig plasmid DNA 
was mixed with 300 units appropriate restriction enzymes and incubated at 37°C for 2 
hours. The digested patterns were observed by electrophoresis of 1% agarose gel with 
50 |ig/ml ethidium bromide. 
2.2.6 RNA Extraction 
DEPC-treated water was used in all the RNA experiments. DEPC was added to the 
deionized NANOpure water (Barnstead, Dubuque, I A) to a final concentration of 0.5% 
and stirred overnight. The water was then autoclaved. 
Tetraodon nigroviridis brain was dissected out, frozen in liquid nitrogen and stored at -
80�C until use. An amount of 10 - 50 mg tissues were homogenized with 1 ml loosely 
fitting Dounce tissue grinder (Wheatson, Millville, NJ) in 1 ml Trizol® and incubated at 
25�C for 5 minutes. An amount of 0.2 ml chloroform was added and the mixture was 
shaken vigorously for several times. It was incubated at 25�C for 3 minutes followed by 
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centrifugation at 11000 rpm at 4°C for 15 minutes, RNA was precipitated from the 
aqueous layer using 500|LI1 iso-propanol. RNA was washed with 70% ethanol, dried on 
air and dissolved in DPEC treated water and incubated for 10 minutes at 60 
2.2.7 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and Construction 
oftnAChE/pCR4 vector 
An amount of 3 |Lig RNA, 1 |LI1 of 50|aM oligo dT, 1 |LI1 10 mM dNTP mix was mixed and 
heated at 65°C for 5 minutes. After incubation on ice for at least 1 minute, 4|LI1 5X First 
strand buffer, 1 |LI1 0.1 M DTT, 1|LI1 RNaseOUT recombinant RNase inhibitor and 200 
units of superscript in were added and incubated at 50�C for 60 minutes. The reaction 
was inactivated by heating at 70�C for 15 minutes. RNase H (2 units) was added and 
incubated at 3 7�C for 15 minutes. For the cloning of tnAChE cDNA, 2 |LI1 C D N A , 1|LI1 10 
mM dNTP mix，1.5 |LI1 10 |LIM forward and reverse primer (forward primer : 5' 
ATGTCAACCTCCGCTCTC-3‘, reverse primer: 5'-TCAGAGGTCGGTGCAGCG -3，） 
and 2 units pfa DNA polymerase with 25 cycles including denaturation 15 seconds at 94 
�C, annealing 30 seconds at 55°C and elongation 2 minutes at 68°C. The 1.8 kb DNA 
fragment was then gene cleaned and cloned into pCR4-Blunt vector using TA cloning. 
2.2.8 Genomic Analysis 
The tnAChE cDNA sequence was mapped to Tetraodon nigroviridis genomic database 
from Genoscope. AChE homologues in human (accession number: NT_007399.14), 
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mouse (accession number: AF312033), and zebrafish (location: ZFISH4:7:20132160-
20175230) were obtained from ncbi genome database. The AChE homologue in 
Takifugu rubripes was obtained by blasting tnAChE against Takijugu rubripes genomic 
database in ncbi genome database, and located in Genebank accession number: 
CAABO100870.1. Multiple sequence alignments were performed using mVista (Mayor 
et al 2000; Bray et al 2003 ； Brudno et al 2003 ； Brudno et al 2003 ； Frazer et al 2004). 
2.2.9 Protein Sequence Analys is 
The tnAChE CDS sequence was predicted by performing a search of open reading 
frames using Translate in expasy sever. (Appel et al. 1994; Wilkins et al 1999; 
Gasteiger et al 2003). The translated open reading frame (ORF) was then blast against 
ncbi protein database (Jenuth 2000). Both the secondary and tertiary structure were 
predicted by GOR (Gamier et al 1996), HNN (Guermerur, 1997)，SSpro (Baldi et al 
1999; Pollastri et al 2002) and SWISS-MODEL (Peitsch et al 1995; Guex and Peitsch 
1997; Schwede et al. 2003) using expasy sever. The tertiary structure was viewed using 
Deepview (Guex and Peitsch 1997). Homologous protein sequences in human 
(accession number: P22303), mouse (accession number: P21836), rat (accession number: 
P37136), torpedo (accession number: CAA27169), Electrophorus (accession number: 
042275) and zebrafish (accession number: Q9DDE3) were obtained from ncbi protein 
database, while homologue in Takijugu rubripes was obtained by gens can (Burge and 
Karlin 1997; Burge and Karlin 1998; Monti and Cooper 1998) of the blast search result 
of tnAChE against Takifugu rubripes, as the mentioned in Section 2.2.8. The active site, 
intermolecular disulphide bonds and t-peptide were identified by their consensus 
sequence in multiple alignments using clustalw. The phylogenetic tree was generated 
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using neighbor joining method by Saitou and Nei (http://www.ebi.ac.uk). The potential 
glycosylation and phosphorylation sites were predicted by SCANPROSITE (Bairoch et 
al 1997; Falquet et al 2002; Sigrist et al 2002; Hulo et al 2006) using PredictProtein 
severs (Rost et al. 2004). The Signal? program was run to predict the putative signal 
sequence (Bendtsen et al 2004). 
2.2.10 Genomic DNA Extraction 
Genomic DNA was extracted from 50-100 mg Tetraodon nigroviridis eyes using 
Genomic DNA isolation Kit. The extracted DNA was dissolved in 8 mM NaOH. 
2.2.11 Construction of Reporter Vectors ptnAChE.ses/pGLS and ptnAChE.iHs/pGLS 
Two tnAChE DNA fragments were amplified from Tetraodon nigroviridis genomic DNA 
using polymerase chain reaction (PGR). The reaction mix contained 100 ng genomic 
DNA, 1 (xl 10 mM dNTP mix, 1.5 \i\ 10 (iM forward and reverse primer (forward primer 
1: 5‘-ATCTCGAGTGCAAGCTAGATGTGG-Sforward primer 2: 5'-ATCTCGA 
GCCGGCATGGAACCCT-35'reverse primer: 5 ‘ -CC AAGCTTGTTGCCCTTG 
CAGAAC-3') and 2 units pfic DNA polymerase was placed in PCR machine 
programmed with 25 cycles (denaturation 15 seconds at 94°C, annealing 30 seconds at 
55°C and elongation 2 minutes at 68°C). The pGL3 basic vector and PCR fragment at 
around 2 kb and 1.5 kb were digested by Xhol and HindUl separately. The digested 
vector was further dephosphorylated by calf intestine alkaline phosphatase. After gel 
clean, 50 ng digested pGL3 basic vector was ligated with the PCR fragment in 1: 3 
molar ratio with T4 DNA ligase at 16�C for 24 hours. The ligation product was 
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transformed into E. coli strain TOP 10 and plasmids were purified by the alkaline method, 
as mentioned in Section 2.2.2 and 2.2.3 respectively. Clones were analyzed by restricted 
digestion, as described in Section 2.2.4 using Xhol and HindUL Positive clones were 
sequenced. 
2.2.12 Luciferase Assay 
The cells (3x10^ cells per well) were seeded in 12-well plates 24 hours before 
transfection using the lipofectamine transfection method. The DNA containing 0.8 jug 
reporter construct and 0.08 |Lig pEGFP-Nl which were diluted in 50 \x\ serum-free 
medium and mixed with lipofectamine in 1:3 ratio using serum-free medium. The 
mixture was incubated for 30 minutes at 25°C to form DNA-lipofectaimine complex and 
then the sample was further diluted to 200 |LI1 with serum-free medium. The cells were 
washed and medium was replaced by serum-free medium. DNA-lipofectamine complex 
was added to cells drop by drop. Equal volume of double serum medium was added to 
cells after three hours. The cells were incubated at 37°C in water-saturated atmosphere 
of 95% air and 5% CO for 2 days. The cells were washed with PBS twice, lysed in 
lysis buffer with freeze and thaw once and then assayed for luciferase activity according 
to the instruction provided from the Luciferase Assay Kit. The luminescence was 
recorded using spectraMAX microplate reader. 
2.2.13 Transcription Factors and Promoter Prediction 
Putative transcription Factors were found by MATCH^^ (Kel etal. 2003) and TFSCAN, 
using the TRACFAC database (Wingender 1988; Faisst and Meyer 1992; Knuppel etal. 
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1994; Heinemeyer et al 1998; Heinemeyer et al 1999; Wingender et al 2000). 
Transcription start sites were predicted by TRANSPLORER (Bajic and Seah 2003). 
The GC rich regions were found using newcpseek in EMBOSS (Rice et al. 2000; Olson 
2002). The tandem repeats were found by RepeatFinder (Volfovsky et al 2001). The 
common conserved non-coding sequences were found from the CNS file generated by 
mVista (Mayor et al 2000; Bray et al 2003; Brudno et al 2003; Brudno et al 2003; 
Frazer et al 2004). The transcription factor binding sites located within conserved non-
coding sequences were also found. The GC pattern of sequences was calculated in 200 
bp window size. Two sets of random sequence data were generated, namely Randseq 
setl and Randseq set2. Randseq setl was generated by a self written program in Perl, 
and Randseq set2 were sequences randomly extracted from genomic sequence of 
Tetraodon nigroviridis in ensembl database. 
2.2.14 Protein Assay 
Protein concentration was determined by the BCA Protein Assay Kit following the 
manufacture's protocol. In brief, samples were diluted with PBS into appropriate 
dilution (2-5 folded dilution). The sample (20 |xl) was then added to 200 |il assay buffer 
(Reagent A and B premixed in 50:1 v/v) and then incubated at 37°C for 30 minutes. 
The absorbance at OD562 was then determined by a plate reader. BSA was used as 
standard for the construction of a protein calibration curve. 
2.2.15 AChE Activity Determined by the Ellman's Method 
AChE activity was determined by Ellman's method (Ellman et al 1961), which was 
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modified by Tsim and his colleagues (Tsim et al 1988). After incubation in 100 mM 
sodium phosphate (Na2PH04) with 0.1 mM iso-OPMA or 1 mM huperzine at the final 
concentration at 25�C for 10 minutes, samples were incubated with 0.625 mM 
acetylthiocholine and 0.5 mM DTNB at the final concentration. The assay was 
monitored at OD410 by mircoplate spectrometer (uQuant Bio-TEK instruments, inc). 
2.2.16 Histochemistry 
Cells were washed with phosphate buffer saline (PBS) twice and fixed in 4% 
paraformaldehyde at 25�C for 20 minutes. AChE activity was stained according to 
Kamovsky and Roots staining procedure (Kamovsky and Roots 1964). After washing 
with PBS and fixation, cells were incubated in 100 mM phosphate buffer, pH 6.1 with 
0.1 mM iso-OPMA for 10 minutes. Then 30 mM of copper (11) sulfate, 5 mg/ml 
acetylthiocholine, 50 mM sodium citrate and 0.5 M ferrihexocynate were added to the 
staining buffer. Staining was continued until the brown precipitate was visible. 
2.2.17 Protein Extraction from Tissues 
Brain, eye, heart, liver，spleen, white and red skeleton muscle of Tetraodon nigroviridis 
were homogenized in lysis buffer 1 (50 mM HEPES, 10 mM EDTA, IM NaCl) and 
0.5% Triton-XI00) using loosely fitting Dounce tissue grinder, followed by 
centrifugation at 14,000 rpm, 4�C for 15 minutes to remove cell debris. The resulting 
supematants were assayed for AChE activity by the Ellman method. 
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2.2.18 Construction of Bacterial Expression Vector His-MBP-tnAChEAC/pfflSMAL 
The tnAChE cDNA which encodes the C-terminal truncated AChE (tnAChEAC) was 
inserted into pHISMAL vector between the EcoRI and Hindni restriction sites. The 
template tnAChE cDNA (50 ng tnAChE/pCR4) was mixed with 1|LI1 10 mM dNTP mix, 
1.5 |xl 10|iM forward and reverse primer (forward primer: 5'-TCAAAG 
CTTCAGTCTGTGATGTTGAGAA-3reverse primer: 5'-TCAGCTTCAGTCTGTGA 
TGTTGAGAA-3') and 2 units pjx DNA polymerase with 25 cycles including 
denaturation 15 seconds at 94°C, annealing 30 seconds at 55°C and elongation 2 minutes 
at 68�C. The pHISMAL vector and PGR fragment were digested by EcoRL and Hindm 
separately. The digested vector was further dephosphorylated by calf intestine alkaline 
phsophatase. After gene clean, 50 ng digested pHISMAL was ligated with PCR 
fragment in 1:3 with T4 DNA ligase at 16�C for 24 hours. The ligation product was 
transformed into E. coli strain TOP 10. The plasmids were purified using the alkaline 
method, as mentioned in Section 2.2.2 and 2.2.3. Clones were analyzed by restricted 
digestion, as mentioned in Section 2.2.4 using EcoRI and HindUL 
2.2.19 Protein Expression in Bacterial Expression System 
An amount of 50 ng of plasmid DNA was transformed into E. coli strain C41 and 
BL21 (DE) as mentioned in Section 2.2.18. Colonies were picked and inoculated in 3 ml 
LB with 100|ig/ml ampicillin at 37�C，260 rpm for 18 hours. Bacteria were then dilution 
to 1: 100 using LB with 100|Lig/ml ampicillin. The culture was incubated in the shaking 
incubator until it reached mid-log phase. The culture was then induced for protein 
expression by the addition of 0.1 mM of IPTG at the final concentration. Bacterial 
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culture was collected at different time points by centrifugation (14,000 rpm) at 25°C for 
2 minutes. The cell pellet was then lysed in 1% SDS. After boiling at 100°C for 5 
minutes, the samples were centrifuged at 14,000 rpm for 30 minutes to remove cell 
debris. The supernatant was used for protein analysis by SDS-PAGE. 
2.2.20 Purification and Thrombin Cleavage of His-MBP-tnAChEAC 
Soluble His-MBP-tnAChE AC was purified using nickel affinity chromatography. The 
bacterial pellet was resuspended in lysis buffer 2 (20 mM Tris-Cl，IM NaCl and 0.5% 
Triton-XI00, pH 8.0), following sonication on ice for 30 minutes. The inclusion bodies 
were separated by centrifugation at 30，000g for 30 minutes at 4°C. The supernatant was 
loaded to the His-bind column, which had been equilibrated with the binding buffer (20 
mM Tris-Cl, 0.5 M NaCl, pH 8.0). After washing with binding buffer, the column was 
eluted with 0.01, 0.05 and 0.1 M imidazole in binding buffer to remove nonspecific 
proteins bound to the column. The His-MBP-tnAChEAC was finally eluted by 0.5 M 
imidazole in binding buffer. The solution containing His-MBP-tnAChEAC was dialyzed 
with PBS, pH 7.4, at 4�C for 3 hours twice using dialyzing membrane. The sample 
containing His-MBP-tnAChEAC was treated with 1 mM thrombin in PBS pH 7.4 at 4口 
to remove the maltose-binding protein tag. 
2.2.21 SDS Electrophoresis 
The protein samples (50 fig) were mixed with 6x SDS sample buffer (50 mM Tris-Cl, 
pH 6.8，100 mM DTT, 2% SDS, 0.1% bromophenol blue, 10% glycerol at the final 
concentration) and boiled at 100�C for 5 minutes. Samples were stacked with 5% 
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polyacrylamide gel (30% acryllamide mix, IM Tris-Cl, pH6.8, 10% SDS, 10% 
ammonium presulfate, TEMED), and then separated by 10% polyacrylamide gel (30% 
acrylamide mix, 1.5 M tris-Cl, pH 8.8, 10% SDS, 10% ammonium presulfate, TEMED) 
in SDS running buffer (25 mM Tris base, 250 mM glycine, pH 8.3, 0.1% SDS). His-
MBP-AChEAC expression level was viewed by Coomassie blue staining. 
2.2.22 Western Blotting 
The protein samples (10 jxg) were electrophoresed as mentioned in Section 2.2.20. 
Proteins were transferred to Immobilon-P membrane using semi-dry method in transfer 
buffer (Tris-Cl, glycine, SDS, 20% ethanol, pH 8.9) at 15V fro 90 minutes. The 
membrane was blocked in 5% non-fat milk in TEST (50 mM Tris-Cl, 150 mM NaCl, 
0.2% Tween-20, pH 8.0) for 60 minutes and then probed with anti-AChE antibody in 
1:5000 or anti-GADPH antibody in 1:100,000 at 4�C for 18 hours. The membrane was 
washed with TEST for five minutes three times and then probed with goat anti-mouse 
IgG antibody in 1:5000 at 25�C for 1 hour. The membrane was then washed with TBST 
for five minutes three times and incubated with ECL reagent for one minutes and 
exposed to x-ray film. 
2.2.23 Construction of the Tet-Off Expression Vector 
The Tet-Off expression vector that expresses C-terminated truncated tnAChE was 
constructed by cloning, the TnAChEAC cDNA into pTRE2hygo vector at Notl and 
EcoRV sites. 2|LI1 C D N A , 1|LI1 10 mM dNTP mix, 1 . 5 ^ 1 10 pM forward and reverse 
primer (forward primer: 5 '-GCGCGGCCGCAAATGTCAACCTCC-3reverse primer: 
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5‘-GAGATATCTCAATCAATGTTGTCTGT-3') and 2 units pjx DNA polymerase. PCR 
reaction was programmed with 25 cycles (denaturation 15 seconds at 94�C，annealing 30 
seconds at 60°C and elongation 2 minutes at 68°C). The amplified DNA sample was 
separated to agarose gel electrophoresis and the DNA band around 1800 bp was excised 
and extracted by the gel clean method. The pTRE2hygo vector and PCR fragment were 
digested by Nod and EcoRV separately. The digested vector was further 
dephosphorylated by calf intestine alkaline phosphatase. After gel clean, an amount of 
50 ng digested pTRE2hgyo vector was ligated using T4 DNA ligase with the digested 
PCR fragment in 1:3 ratio at 16�C for 24 hours. The ligation product was transformed 
into E. coli strain TOPIO and the plasmid DNAs were purified from the bacteria culture, 
as mentioned in Section 2.2.2 and 2.2.3 respectively. The picked clones were analyzed 
by restricted digestion, as mentioned Section 2.2.4 using Notl and EcoRV. Positive 
clones were confirmed by DNA sequencing. 
2.2.24 Transient Expression of tnAChEAC 
The CHO cells (4x10^ cells per well) were seeded in 6 well-plates 24 hours before 
transfection. A DNA mixture containing 2 DNA plasmid and 0.2 |ig pEGFP-Nl was 
diluted in 100 |LI1 serum-free MEMa and mixed with lipofectamine, which was diluted in 
100 \i\ in 1:3 to the amount of DNA. The mixture was incubated at 25�C for 30 minutes 
to form DNA-lipofectamine complex. The DNA-lipofectamine complex was further 
dilution to 400 \i\. Cells were washed with PBS and medium was replaced by serum-
free MEMa. DNA-lipofectamine complex was added to the cells drop by drop. After 
incubation at 37°C for 3 hours in water-saturated atmosphere of 95% air and 5% CO, 
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double serum MEMa was added to the cells. Cells were harvested 3 days after 
transfection. Cells were washed by PBS twice, and lysed by the lysis buffer with freeze 
and thaw once. Crude extract was centrifuged (14,000 rpm) at 4°C for 15 minutes to 
remove cell debris. The extract was analyzed for AChE activity by the Ellman's method 
as mentioned in Section 2.2.15. 
2.2.25 Establishment of Stable Tet-Off CHO Cell Lines Overexpressing tnAChEAC 
The procedure for DNA transfection was done as mentioned in Section 2.2.24 except 
that pEGFP-Nl vector was not included in the DNA-lipofectamine mix. Three hours 
after adding the double serum medium, the cells were spitted into two 100 mm dishes 
with 800 }xg/ml hygromycin and 2 |ig/ml doxycycline. The cells were incubated at 37�C, 
5 % CO2 with 100% humidity. After incubation for 10 days, colonies were picked， 
induced by removal of doxycycline and screened for AChE activity by the Ellman assay 
as mentioned in Section 2.2.15. 
2.2.26 MTT Assay 
Cell viability was determined by the MTT assay�The cells ( 4 x 1 c e l l s per well) were 
seeded in 96-well plates 24 hours before induction of tnAChEAC expression. After 
removing doxycycline for 18 hours, 50 |il MTT assay reagent was added into each well 
and incubated at 37�Cin water-saturated atmosphere of 95% air and 5% CO for 3 hours. 
An amount of 100 |il DMSO was then added to dissolve the crystal formed. After 
shaking for 30 minutes, reading was taken at OD570 using microplate spectrometer 
(uQuant, Bio-TEK instrument inc.). 
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2.2.27 Partial Purification of tnAChEAC 
tnAChEAC was partially purified from crude extract using ammonium sulfate 
precipitation. Ammonium sulfate was added to crude extracts to 40% saturation on ice, 
followed by centrifugation at 4°C, 14.000 rpm for 15 minutes. The pellet was discarded. 
Ammonium sulfate was again added to supernatant to 80 % saturation on ice, followed 
by centrifugation at 4�C, 14,000 rpm for 15 minutes. The supernatant was discarded, 
while the pellet was dissolved in lysis buffer 1. The supernatant enriched in tnAChEAC 
was further purified by high performance liquid chromatography gel filtration (HPLC-
Gel) on a Superdex 75 10/300 GL column. The ammonium sulfate precipitated fraction 
was re-dissolved in elution buffer and then loaded onto the HPLC column. Proteins 
were eluted in elution buffer (50 mM HEPES, 10 mM EDTA, 0.15 M NaCl, pH 7.4) at 
the flow rate 0.3 ml/min. Twenty fractions (0.9 ml per fraction) were collected and 
AChE activity was determined as mentioned in Section 2.2.15. 
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Chapter 3 Sequence Analysis of AChE Gene of Tetraodon nigroviridis 
3.1 Results 
3.1.1 Cloning of tnAChE from Tetraodon nigroviridis Brain 
AChE is expressed predominantly in the brain, red skeleton muscle and eye. To 
clone the brain AChE, the total RNA of the brain was prepared for RT-PCR. A 
single amplified DNA of 2155 bp in length was obtained. The nucleotide sequence 
is shown in Appendix 1. The search for open reading frame identified the 1860 bp 
sequence which encodes a protein of 620 amino acid residues. The cDNA sequence 
was mapped to Tetraodon nigroviridis genomic database in Genoscope. Nine 
putative exons in Un-random chromosome were mapped with consensus splicing 
pattern. The gene structure is shown in Figure 3.1. The homologous AChE in 
Takifugu rubripes was found by blasting tnAChE cDNA against Takifugu rubripes 
genomic database. Nine exons were mapped along the same contig. The CDS of 
Takifugu rubripes AChE was predicted by Genescan. The translated CDS is over 
90% identical to the tnAChE protein sequence. 
3.1.2 Comparative genomic analysis of tnAChE with Human, Rat, Mouse, 
Takifugu rubripes and Zebrafish AChE genes 
The conserved sequence of tnAChE genomic sequence was found by mVista. By 
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alignment with AChE gene in human, mouse, zebrafish and Takifugu rubripes using 
tnAChE as the base organism, it is shown that the CDS was the most conserved 
region, except exon 8 when comparing it with the mammalian AChE. The most 
conserved non-coding sequences were also found in the 5' upstream sequence of 
exonl, intron 1 and intron 8, as shown in Figure 3.1. No conserved non-coding 
sequence was found in the corresponding tnAChE intron 2, 3 and 4 in homologues in 












































































































































































































































































































































































































































































































































3.1.3 Primary Sequence Analysis 
TnAChE encodes for a protein of 620 amino acid residues with the first 24 amino 
acids predicted as the signaling sequence. Figure 3.2A shows the multiple 
alignments of primary sequences of AChE from different species using clustalw 
(version 1.83) The tnAChE is 73.3%, 84.1% and 78.2% similarity to human 
AChE-T form, zebrafish AChE and torpedo AChE-T. Among teleosts, tnAChE 
shows much higher similarity to the predicted sequence of Takifugu rubripes AChE 
than that of zebrafish AChE (Figure 3.2B). Moreover, AChE is more divergent in 
teleosts than in mammals. The active sites (serine, glutamine and histidine), 
intramolecular disulphide bridges and t-peptide of AChE are conserved among 
vertebrates� An extra internal sequence of tnAChE was found when comparing 
tnAChE with its mammalian homologues. From three dimensional modeling using 
SWISS-MODEL, this fragment was located on the protein surface as a loop, and it 
was predicted to be a helix by secondary structures analysis using GOR, HNN and 
SSpro (Figure 3.3). The six potential glycosylation sites were located at position 21, 
134, 284, 369, 498 and 578. The predicted three dimensional structures by 
SWISS-MODEL are shown in Figure 3.4. The coordinates of the predicted model 
was based upon protein data bank (pdb) entries leve, laiiA, IgqrA, IgqsAand IjjbA 
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which shares at least 65 % similarity. 
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A CLUSTAL W (1.83) multiple sequence alignment 
eeAOiE — ——MKILDALLFP V i FI IFF ！ H — LS IAQTDPELTIMTRU3QVQGTRLPVP0RSH 50 
drAChE 41KTSD i LLLP-TVLUFLFH—-NCRQAEPDLWATRLGRVQGTRLPVPORSH 50 
tnAChE MSTSALOTSPI ILLS 1F IP—-/裕‘左:X}TEADLFVQTRTGR IRGIHLPVPORGY 51 
trAOiE M L T S 1 L V F F S S L F L L P L F ! P—DCSCQTETDLYVQTLAGRVRGVHLPVSDRSY 511 
tcAOiE — MNLLV7SSLGVLLHLW-- - -LCQADDHSELLVNTKSGKVMGTRVPVLS -SH 47 
rnAOiE MRPPWYPLHTPSLASPLLFLLLSLLGGGARAEGREDPQLLVRVRGGCIRGIRLKAPGHSP 59 
mmAOiE MRPPWYPLHTPSLAFPLLFLLLSLLGGGARAEGREDPdLVRVRGGdRG IRLKAPG-GP 59 
hsAOiE MRPPQCLLHTPSLASPLLLLLLWLL6GG^GAEGREDAELLVTVRGGRLRGIRLKTPG-GP 59 
eeAChE VIAFLGIPFAEPPLGK嫩FKPPEPKKPWNDVFDARDYPSAffQYVDTSYPGFSGTE應NP 110 
drAOiE VIAFLGIPYAEPPIGKRRFKRAEPKKPWNNVFEAKEFSN#QFVDTSYPGFPGIEMWNP 110 
tnAChE VTAFLGI PFAEPPV6K(^FRRPEPKRPWTGLYEANAYPN#QYVDTTPGF0GSEMWNP 111 
trAChE VTAFLG IPFAEPPVGKRRFRHPEPKRQWSGLYEANAYPNMQVVDTSPGFQGSEMWNP 111 
tcAChE 丨 SAFLG 丨 PFAEPPVGNMRFRRPEPKKPWSGVWNASTYPN_QYVDE(3FPGFSGSEM侧P 107 
rnAOiE VSAFLGIPFAEPPVGSRRFMPPEPKRPWSGI LDATTFQN#QYVDTLYPGFEGTEMWNP 119 
nimAChE VSAFLG I PFAEPPVGSRRFMPPEPKRPWSGVLDATTFQN\|fQYVDTLYPGFEGTB_P 119 
hsAChE VSAFLG I PFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVlrQYVDTLYPGFEGTEMWNP 119 
：****** ： ***+ ： * *+ . **+： *. . ： ： * : . E^ * 本氺：*** * ***** 
eeAOiE NRMMSEDIILYLNVWVPATPRPHNLTVMIYGG GFYSGSSSLDVY 155 
drAOiE NRVMSEI^YLNVWVPPTPRPQNLTVMV^ViYGG — GFYSGSSSLDVY 155 
tnAChE NREMSEliLYLNVWVPPSPRSHyVZ TlWfi I YGG GFYSGSSSLDVY 156 
trAChE NREMSED|‘YLNVWVPSSPRSHNLTVMVWIYGGATLMRNVRSADAIFAGFYSGSSSLDVY 171 
tcAChE NRB/ISEIM.YLN IWVP-SPRPKSTTVMVWI YGG GFYSGSSTLDVY 151 
rnAOiE NRELSED^YLNVWTPYPRPTSPTPVLIWI YGG- — GFYSGASSLDVY 164 
mniAChE NRELSED^YLNVWTPYPRPASPTPVL IWI YGG GFYSGAASLDVY 164 
hsAChE NRELSECyLYLNVWTPYPRPTSPTPVLVW I YGG GFYSGASSLDVY 164 
林 ： * 林 林 林 林 林 林 林 林 * 
eeAOiE DGRYLAHSEKVVVVSMNYRVSAFGFLALNGSAEAPGNVGLLDQRLALQWVQDNIHFGGN 215 
drAChE DGRYLAYTEKVVVVSMNYRVGAFGFLALNGSSDAPGNVGLYDQRLALQWVQENIHFFGGN 215 
tnAChE DGRYLAHTESVIWSVNYR 丨 GAFGFLALHGSTEAPGNVGLLDQRLGLQWVQDNIHFFGGN 216 
trAC^E DGRYLAHSESIIVVSVNYRIGAF6FLALHGSAEAPGNAGLLDQRLGLQWVQONIHFFGGN 231 
tcAChE NGKYLAYTEEVVLVSLSYRVGAFGFLALHGSQEAPGNVGLLDQRMALQWVHDNIQFFGGD 211 
rnAChE DGRFLAQVEGTVLVSMNYRVGTFGFIAU^GSI^APGNVQlDQRLALQWOEN IAAF6QD 224 
mfnAOiE DOIVIAQVEGAVLVSMNYRVGTFGFLAU^GSREAPGNVGLLDORLALQWVOEN lAAFGGD 224 
hsAChE DGRRVQAERTVLVSMNYRVGAFGFLALPGSF€APGNVGIIJ)QRLALQWQENVAAFGGD 224 
* * • 士 士 * •�jj-jj * 士士 “ • 士*^  -Jjiir •ir\ir * 士士 J^j^ Jc “ iiy^  K-vL-Jj * •士 • 士^ 上^• 
, * • , F 擎 * « • W 4 • * * « • VR N^ ^ W 等不千 W 甲予，_ •.予千 ^^ » . ^  . » 
eeAOiE PKQVTIFGESAGAASV6MHLLSPDSRPKFTRAILQSGVPNGPWRTVSFDEARRRAIKLGR 275 
drAChE PKQVTIFGESAGAASVGMHVLSPDSRPLFTRAILQSGVPNTPWATVTFDGARRRTTKLGK 275 
tnAChE PKQVTIFGESAGAASV6FHLLSPGSRHTFTRAIFQSGVPNSPWASVTPAEARRRATTLGK 276 
trAChE PKQVTIFGESAGAASVGFHLLSPGSRPTFTRAILQSGVPNSPWASVTPAEARRRABilUN 291 
tcAChE PKTVTIFGESAGGASVGMHILSPGSRDLFRRAILOSGSPNCPWASVSVAEGRRRAVELGR 271 
rnAOiE PMSVTLFGESAGAASVGMHILSLPSRSLFHRAVLQSGTPNGPWATVSAGEARRRATLUR 284 
mmAChE PMSVTLFGESAGAASVGMHILSLPSRSLFHRAVLQSGTPNGPWATVSAGEARRRATLLAR 284 
hsAChE PTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQUH 284 
^ ^ •平•^^^^不-•不-，不 ^ ^ 予 个中• •中^^ ^ ，个 予予 • ^  平 ， . 平* • 
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eeAChE HKGLKSQPkMWNRFLPRLLNV M I 630 
drAChE HKGLRTQF IWNRFLPRLLNI ’ DmD{)VERG|<V_HPpSs|(M||<S(|^Hfl^KQe^ 631 
tnAChE HRGMRNQ^' AFWDRFLPRLLA7 I DEAERGfiKV_HR|jSS|MMH^S(:^ DH#KQER| 617 
trAChE HRGLRNOV i\FWDRFLPRLLN I • DNI 631 
tcAChE HORLRVQ^  7FWNQFLPKLLNA_ ET I 593 
rnAChE RRGLRAQ7 F^WNRFLPKLLSA" DTL[)EAER(iiKA_HRiss|MVH^N(^H@KQEF^ 611 
mmAChE RRGLRAQl F^WNRFLPKLLSA‘ 1 
hsAChE RRGLRAQAfcPWNRFLPKLLSAlnTI nFftFRIMAmW^VWNIlBnHt^Kfin^ 611 
eeAOiETni 633 
drAChE TD 634 
tnAChE TD , 620 
trAChE TD 634 
tcAChE AE 596 
rnAChE SD , 614 
mmAChE SD 614 
hsAChEjSQI 614 
: :* 
B mil �e mmAChE 
1 eeAChE 
y / ^ ^ t n A C h E 
tcAChE 
Figure 3.2 
A. Multiple alignment of AChE homologues from human (hsAChE), mouse 
(mmAChE), electrophorus (eeAChE), torpedo (tcAChE), zebrafish (drAChE), 
Tetraodon nigroviridis (tnAChE), rat (rnAChE) and Takifugu rubripes (trAChE) 
using clustalw (version 1.83). Close red, yellow and green boxes indicate 
conserved cysteine, active sites and aromatic rings in WAT domain respectively, 
while open green boxes denote t peptide. Underlined sequence represents 
extra internal sequence compared to mammalian AChE. Predicted 
glycosylation sites are shown in italic. Asterisks, semicolon and dots indicate 
identical, higher and lower similarity. Dark blue, blue and slight blue colors 
indicate identical, higher and lower similarity in teleosts. 
B. Phylogenetic tree generated according to AChE multiple alignments in Figure 
























































Figure 3.3 Secondary Structure prediction of tnAChE protein using GOR, HNN and 
SSpro. H, e, and c denote a helix, p sheet and coli respectively. Underlined 




Figure 3.4 AChE tertiary structures predicted by SWISS-MOLEL. 
A. Overall predicted structure of tnAChE. White arrow indicates the extra 
sequence compared to mammalian AChE. 
B. Predicted structure of active site in tnAChE. 
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3.1.4 Promoter and Transcriptional Factors Predicted in \x\AChE Promoter Region 
The promoter region was predicted to cluster in the region at -1143 to + 569, where 
+1 represents the first nucleotide of exon 1 obtained by 5' RACE. Two fragments 
of \x\AChE promoter region were constructed and cloned into the luciferase-based 
reporter vector for experimental confirmation of promoter activities. They were 
-1143 to +781, ptnAChE.1143, and -565 to +781, ptnAChE.565. 
Promoter Region Analysis In Silico 
The GC-rich regions were found at positions -1099 - -967, -366 — -14, +26 - +40, 
156 — 314 and 336 - 354 using newcpgseek in EMBOSS. The GC content in the 
AChE promoter regions in Tetraodon nigroviridis, Takifugu rubripes and zebrafish, 
human and mouse were shown in Figure 3.5, Peaks were observed at the 
transcription start sites in all species. The promoter regions of teleost AChE, with 
maximum length 2000, were compared with random sequence data as shown in 
Figure 3.6. Two set of random sequences were generated (Randseq setl and 
Randseq set2). Randseq setl is composed of 100 sequences, which is randomly 
generated by a self-written program in Perl. Randseq set2 has 104 sequences. It 
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A. CG pattern of teleosts AChE promoter regions. Tn, tr and dr denote AChE 
promoter regions in Tetraodon nigroviridis and Takifugu rubripes and zebrafish. 
The patterns are aligned at the transcription start sites. 
B. CG pattern of mammalian AChE promoter regions. Hs and mm denote AChE 
promoter regions in human and mouse respectively. 
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Figure 3.6 
A. CG pattern of AChE promoter regions in teleosts and random sequence data set 
1. 
B. CG pattern of AChE promoter regions in teleosts and random sequence data set 
2. 
The random sequence data sets are generated according to Section 3.2.Orange 
line shows the mean eg percent of the random sequence data, whereas the 
yellow band shows the maximum and minimum CG percent. The CG pattern 
of AChE promoter regions in teleosts are aligned at the transcription start site. 
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nigroviridis genomic database at ensembl, following removing sequences with 
unknown nucleotides. The nucleotide compositions of AChEs are shown in Table 
3.1. Generally speaking, the nucleotide composition of RandSeq set2 is similar to 
teleost AChE promoter regions than RandSeq setl. The GC content in promoter 
region of teleost AChE is lower than that in mammalian. However all the promoter 
region of vertebrate AChE shows a similar GC pattern, a maximum GC% clustering 
around the transcription start site. There are four repeats at positions 513 - 542, 
579 一 597, 694 - 708 and 712 — 730 located in intron 1. The repeated pattern 
between positions 513 - 542 (TCAT) is identical to the pattern found in Takifugu 
rubripes AChE promoter region located in the intron 1. Two transcription start sites 
at positions -24 and +86 were predicted using TRANSPLORER. E boxes were 
found at positions -959, -849，-677, -675, -631, -518, -424, -364, 98, 506, 563 and 
760 on ptnAChE.1143. Transcriptional factors Pax-6, CCAAT box, NF-Y, HNF-1, 
C/EBP, GATA-3 and Oct-1 were predicted on ptnAChE.ii43 by MATCW^ (Table 
3.2). Over 20 transcriptional factors were predicted using TFSCAN, which 
includes Spl, TBP, TFIID and CREB and the results are tabulated in Table 3.3. The 
schematic summary of the predicted transcription factors is shown in Figure 3.7. 
63 
Data set A% C � / � G � / � TO 
tn 29.5 20.3 19.9 30.3 
dr 30.6 (32.1) 18.9 (18.2) 18.5 (18.2) 32.0 (31.5) 
tr 25.6 (26.2) 21.8 (20.5) 23.8 (20.6) 28.8 (32.7) 
hs m ^ 20.7 
mm 24.9 27.0 24.6 23.5 
RandSeq setl 24.9 ± 1.0 25.0 ±0.9 25.1 ± 1.0 25.1 ± 1.0 
RandSeq set2 26.0 ±1.9 219 + 0.1 22.2 ± 0.2 27.9 士 1.8 
Table 3.1 Nucleotide compositions of vertebrate AChE promoter regions. 
Nucleotide compositions were calculated in Tetraodon nigroviridis (tn), zebrafish 
(dr), Takifugu rubripes (tr), human (hs), mouse (mm) and random sequence data sets. 
The numbers shown in baskets are the nucleotide compositions of the sequences used 
in Figure 3.6. For the random sequences data, GC content is shown in mean 士 
standard deviation. 
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Species tn tr dr hs mm 
Transcription -Oct-] -Oct-] -Oct-I -AP-4 -Oct-1 
factor -C/EBP -CCAAT -C/EBP -CDPCRl -AP-1 
-CCAAT box -Cart-1 -CHOP-C/E -Brn-2 
box -CDPCRl -CCAATbox Ba -c-Ets-l(p54) 
-GATAS -c-Rel -CDP CRl -CP2 -CHOP-C/EB 
-HNF-1 -Evi-1 -CHOP-C/E -CRE-BPl P a 
-NF-Y -F0XD3 BP a -c-Rel -c-Rel 
-Pax-6 -F0XJ2 -COMPl -Elk-1 -Elk-1 
-GATA-3 -CREB -GATA-3 -Evi-1 
-HLF -Evi-2 -Handl/E47 -F0XD3 
-HNF-1 -F0XD3 -HLF -GATA-3 
-NF-Y -F0XJ2 -HNF-1 -Handl/E47 
-Pax-4 -Handl/E47 -ISRE -HNF-1 
-Pax-6 -HLF -Nkx2-5 -HNF-3 /5 
-HNF-1 -Pax-4 -MyoD 
-HNF-3 3 -STATx -NF-E2 
-MEISIB/H -USF -Nkx2-5 
0XA9 -VBP -Pax-4 





Table 3.2 Transcription factors on ptnAChE.1143 using MATCH^m with vertebrate 
matrices after minimizing false positive. Common transcription factors that are 
predicted in any four sequences are underlined and common transcription factors 
binding sites of teleost AChE are in italic. 
65 
tn tr dr hs mm 
ACF ACF AFPl ACF ( r ) O B P 
AFPl a-CBF a-CBF AFPl ACF 
a-CBF a-IRP a-IRP a-CBF AFPl 
a-IRP AP-1 AP-1 a -IRP a -CBF 
AP-1 ATF ATF AP-2 a -IRP 
AP-2 ATF-3 C/EBPa ATF AP-1 
C/EBP r C/EBP(5 C/EBPr C/EBPr AP-2 
CAC-binding CAC-binding CAC-binding CAC-binding ATF 
protein protein protein protein C/EBP a 
CBF-B CBF CACCC- CACCC- C/EBP y 
CCAAT-binding CBF-B binding factor binding factor CAC-binding 
factor CCAAT-binding CBF-B CBF-B protein 
c-Ets-2 factor CCAAT binding CCAAT-bindi CACCC-
c-Myb CDP2 factor ng factor binding factor 
CPl c-Ets-2 CDP2 CDP2 CBF-B 
CP2 c-Jun c-Ets-2 c-Ets-2 CCAAT-bindi 
CREB c-Myb c-Jim c-Myb ng factor 
ER CPl c-Myb CPl CDP2 
ETF CP2 CPl CP2 c-Ets-2 
F2F CREB CP2 CREB c-Myb 
GATA-1 CTF CREB CSBP-1 CPl 
GR ER CSBP-1 CTF CP2 
HiNF-A ETF CTF E2F-1 CREB 
HITF2 F2F DBP ER CTF 
HNF-1 rCAAT 5 factor ETF Da 
HOXDIO rCAC2 EBP-45 F2F E12 
LF-Al GATA-1 Fral T CAC2 E47 
LyF-1 GATA-2 r CAAT GATA-1 ER 
muEBP-C2 GR r CAC2 GATA-2 ETF 
NF-1 GR 13 GATA-1 GCF F2F 
NF-E H1TF2 GATA-2 GR Fral 
NF-E2 H4TF-1 GR H1TF2 r CAC2 
Table 3.3 (continuing) 
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tn tr dr hs mm 
NF-Y HiNF-A GR /5 H4TF-1 GATA-1 
Pit-la HNF-1 H1TF2 H4TF-2 GATA-2 
PTF1-/5 HOXDIO H4TF-1 HiNF-A GR 
Spl IRF-2 H4TF-2 HiNF-C GR J3 
TBP LF-Al HiNF-A fflPl H1TF2 
TCF-IA LyF-1 HNF-3 HNF-1 H4TF-1 
TFE3-S NF-1 IgPE-2 IgPE-1 H4TF-2 
TFIID NF-E IRF-2 IRF-2 HiNF-A 
TGGCA- NF-E2 LF-Al LF-Al HiNF-C 
binding protein NF-Y MEP-1 LyF-1 IgPE-1 
vHNF-I Oct-1 muEBP-C2 MEP-1 IRF-2 
PEAS NF Ill-e muEBP-C2 IUF-1 
Pit-la NF-1 myogenin LF-Al 
PPYR NF-A NF-1 MAZ 
PR NF-A3 NF-E MEP-1 
PTF1_ 冷 NF-E NF-E2 muEBP-C2 
PU.l NF'E2 NF-A:E2 MyoD 
Spl NF-zcBl NF-Y NF-1 
T3R-运 2 NF-Y Pit-la NF-A 
TBP Oct-1 PU.l NF-E 
TCF-IA Oct-lC Spl NF-E2 
TDEF Oct-2 T3R-/52 NF-/cE2 
TFIID Oct-2.1 TBP NF-Y 
TGGCA- Oct-2B TDEF NF-Zc 
binding protein PEAS TFE3-S Oct-1 
TGT3 Pit-la TFIID Oct-2 
TMF PR TGGCA- Octa-factor 
vHNF-1 PTFl-;5 binding octamer-bindi 
Spl protein ng factor 
T3R-/32 TGT3 PEAS 
TBP vHNF-1 Pit-la 
TFE3-S v-Jun PTFl-y5  
TFIID Wn PU.l 
Table 3.3 (continuing) 
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tn tr dr hs mm 
TGGCA-bindi Sp-1 












Table 3.3 Transcription factors predicted on different species AChE promoter regions 
using TFSCAN. Human, mouse, Tetraodon nigroviridis, Takifugu rubripes and 
zebrafish are denoted as hs, mm, tn, tr and dr respectively. Common transcription 
factors of five promoter regions are bolded. 
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f l “ I 上 ^ g h t a j n I 
-1001 -801 -601 -401 -201 1 201 401 601 
Predicted by M A T C H ™ Predicted by TFSCAN 
OCT-1 ‘ repeat 
^ A Sp1 I CG rich region 
• CREB I E box I CAAT box or NFY ‘ T DOX 
I HNF1 TBP LJ Transcriptional start site 
A TFIID 
I C/EBP • Exon 1 
Figure 3.7 Schematic diagram of ptnAChE.1143 
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In order to reduce the false positive of transcription factor binding sites in promoter 
region of tnAChE, common transcription factors that were predicted in different 
vertebrate AChE promoter regions were found. C/EBP, Oct-1, GATA-3, HNF-1 and 
Pax-6 were common in at least four promoter regions of AChE examined. All 
examined teleost AChE promoter regions have putative CCAAT box, which was 
missed in the mammalian counterparts. Twenty putative transcription factors 
predicted by TFSCAN are common in all sequences examined. They are a-CBF, 
a-IRP, CAC-binding protein, CCAAT-binding factor, c-Ets-2, c-Myb, CPl, CP2 
CREB, GATA-1, HITF2, LF-Al, NF-1, NF-E, NF-E2, NF-Y, Pit-la, Spl, TBP, 
TFTTD and TGGCA-binding protein. There is no interaction between two sets of 
common transcription factor predicted by MATCH™ and TFSCAN for all sequences 
analyzed. The CCAAT box is consistently predicted in teleost both in M A T C H ™ 
and TFSCAN. By comparing the transcription factor binding sites among teleost, 
CCAAT box with Oct-1 and HNF-1 with Oct-1 are common combinations of 
transcription factor binding sites predicted in the promoter region of Tetraodon 
nigroviridis and zebrafish (Figure 3.8). 
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t n丨丨丨丨_ 
dr 1 丨 1 W n  
tr H ~ ‘ ^ H - T ^ ~ ‘ ~ 
— 1 k b 
Figure 3.8 Transcription factor binding sites on promoter region of teleost AChE. 
Tetraodon nigroviridis, zebrafish and Takifugu rubripes are denoted as tn, dr and tr. 
respectively. Red, brown, pink and blue boxes denote Pax-6, HNF-1, Oct-1 and 
CCAAT box respectively. 
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An alternative method to reduce the number of false transcription factor binding sites 
is to find transcription factor binding sites in the conserved non-coding sequences. 
Conserved non-coding sequences were obtained by mVista, which identifies 
conserved non-coding sequences by global alignment AVID. The common 
conserved non-coding sequences were identified by the overlapping region of 
conserved non-coding sequences from different species using tnAChE promoter 
region as base sequence. Takifugu rubripes and Tetraodon nigroviridis, seemed 
sharing a large portion of conserved non-coding sequences, especially at the 3’ 
downstream of the transcription start site of tnAChE. Conserved non-coding 
sequences were also found in zebrafish, mouse and human. However, no common 
conserved non-coding sequence was identified among all species examined. 
Common conserved non-coding sequences were identified in AChE promoter region, 
as shown in Figure 3.9. In general, the common conserved non-coding sequences 
are short and less than 10 bp. Table 3.4 shows the transcription factors predicted by 
MATCIFM using vertebrate matrices. Both score and matrix score greater or equal 
to 0.9 are located on the conserved non-coding sequences of ptnAChE.1143. Sixteen, 
two, three and two transcription factors were found in the conserved non-coding 
sequences when compared to Takifugu rubripes, zebrafish, human and mouse 
respectively. No common transcription factors on the conserved non-coding 
72 
sequences were found. 
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d r l l l l l l l l l l l l l l llllllllllllll m i l lllllllllll 
m m 11III III I I nil n i l I I nil I nil 11 
h s I I I nil I I I I I IIIII III III III I 
t r , d r I 
m m , h s I I I I I I I I 
t r , dr , h s | 
t r , dr , m m 丨 ‘ i 
d r , h s , m m 
1 k b 
Figure 3.9 A comparison of the conserved non-coding sequence at the promoter 
region of tnAChE with other vertebrate AChEs. Promoter region of AChE in 
Takifugu rubripes, zebrafish, mouse and human are denoted tr, dr, mm, and hs 
respectively. Red bars are the common non-coding region, and the purple box is the 
tnAChE exon 1. The conserved sequences refer to the promoter region of tnAChE. 
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tr dr hs mm 
Lmo2 complex AREB6 Lmo2 complex Nkx2-5 














TATA box  
Table 3.4 Transcription factors on different conserved non-coding sequences of 
ptnAChE.1143 found by global alignment with different vertebrate AChE promoter 
regions. Transcription factors were predicted by MATCEF^ using vertebrate 
matrices and both core and matrix score are at least 0.9. 
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3.1.4.2 Promoter Activity Analysis 
The sequences of ptnAChE.1143 and ptnAChE.565 were cloned into luciferase-based 
reporter vector pGL3. Transfection of the vectors on cultured cells was assayed for 
luciferase activity for the validation of gene promoter activity in this DNA region. 
As shown in Figure 3.10, both ptnAChE.565 and ptnAChE.1143 construct did not show 
a significant change in luciferase activity compared to the promoterless control in 
undifferential C2C12 and SH-SY5Y cells. 
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ptnAChE 
-565a- ^ 1 
1 h u e I ‘ 
ptnAChE-1143’ P W i ‘ 
—— ： -H 
H u e — ^ 
Promoterless  — Hue n 1 1 1 1 1  
0 1 2 3 4 5 6 
Relative promoter activity 
Figure 3.10 Luciferase activities of different fragments of XnAChE promoter region. 
The pGL3-CMV (CMV) vector was transfected to the cells as positive control for 
luciferase assay. No significant activation of promoter activity in ptnAChE.1143 and 




AChE is an important carboxylesterase found in all vertebrates. The genes and their 
corresponding mRNAs for AChE have been cloned in human (Soreq et al. 1985; 
McTiernan et al 1987), mouse, rat (Atanasova et al 1999), torpedo (Taylor et al 
1974) and zebrafish (Bertrand et al. 2001). AChE is also expressed in invertebrates 
such as Drosophila and C. elegans. Recently AChE is also found in pea (Melanson et 
al. 1985; Muralidharan et al 2005), Several copies of C. elegans AChE were 
reported (Johnson et al. 1988; Arpagaus et al 1994; Culetto et al 1999). In the 
study, the gene and cDNA for AChE of Tetraodon nigroviridis (tnAChE) was 
characterized. Figure 3.1 shows the mapping of the cloned tnAChE cDNA to its 
genome and the genomic alignment. It has been suggested that the genomic 
structure of tnAChE is different from its mammalian and zebrafish homologues (Li et 
al. 1991; Bertrand et al 2001). Human jCM" contains six exons with alternative 5’ 
and 3’ splicing (Li et al 1991)� In zebrafish, five exons were found without any 5' 
or 3，alternative splicing (Bertrand et al 2001). Splitting of exon 2 of zebrafish 
AChE seemed to occur when Tetraodon nigroviridis was diverged from zebrafish. 
It is also likely to be the case in Takifugu rubripes AChE, as nine putative exons with 
consensus splicing sites were mapped using tnAChE mRNA against Takifugu 
rubripes genome (Figure 3.11). It was reported that intron size of Tetraodon 
78 
nigroviridis was more frequently at the lowest limit of the intron size in general 
(Jaillon et al 2004), but the size of intron 1 of tnAChE was probably larger than in 
mammalian AChE, similar to the intronic organization of zebrafish. As there is no 
sequence information available in the region of the tnAChE gene in the published 
Tetraodon nigroviridis genome, AChE homologue in Takifugu rubripes could provide 
some insight on the intron 1 of XnAChE. Takifugu rubripes and Tetraodon 
nigroviridis are closer in evolution than zebrafish and Tetraodon nigroviridis. 
Takifugu rubripes diverged from Tetraodon nigroviridis 1 8 - 3 0 millions years ago. 
By mapping tnAChE mRNA to Takifugu rubripes genome, the intron size of Takifugu 
rubripes AChE intron 1 was about 7.5 kb (Figure 3.11), which is longer than the 
reported intron 1 either in zebrafish AChE, which is about 5kb, and mammalian 
AChE, which is about 2.5kb. It suggested that the intron 1 of XnAChE gene is 
around 7kb. 
The exon 8 of XnAChE gene does not have any similar sequence to any sequences in 
the mammalian AChE genes. This exon encodes an extra internal sequence in 
tnAChE. Although such extra insert sequence was also found in zebrafish AChE 
(Bertrand et al 2001), the amino acid residues of this extra sequence vary 
significantly among the two species of fish. At present, the functional and 
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physiological significance of this additional stretch of amino acid residues in tnAChE 
is unclear. 
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Takifugu rubripes AChE 
^ E1 E2 E3 E4 E5 E6 E7 E8 E9 
Hi • ~ H • • • I 1-
1 kb CAAB01000870.1 
B tn.start tr.start tn.end trend length % similarity 
1096 (10661) to 1106 (10671) = I1bp at 72.1% noncoding 
1161 (12375) to 1222 (12438) : 64bp at 68.8% noncoding 
1229 (12445) to 1436 (12648) = 215bp at 72.1% exon 
1442 (12664) to 1502 (12708) = 61 bp at 60.7% noncoding 
1516 (12794) to 1617 (12895) = 105bp at 68.6% noncoding 
1638 (12922) to 1786 (13063) = 157bp at 68.8% noncoding 
2830 (17880) to 2845 (17895) = 16bp at 68.8% noncoding 
2929 (19403) to 2998 (19461) = 70bp at 57.1% noncoding 
3009 (19706) to 3204 (19922) : 219bp at 68.0% noncoding 
3214 (19932) to 3716 (20433) = 505bp at 83.4% exon 
3717 (20434) to 3770 (20485) = 58bp at 58.6% noncoding 
3817 (20490) to 3828 (20501) = 12bp at 75.0% noncoding 
4041 (20517) to 4150 (20627) = 113bp at 65.5% noncoding 
Figure 3.11 
A. Genomic structure of Takifugu rubripes AChE. The structure of Takifugu 
rubripes was determined by blast searched of Takifugu rubripes genomic 
database in ncbi using XnAChE mRNA. The AChE is located in 
CAAB01000870.L 
B. Conserved regions of tnAChE and Takifugu rubripes AChE around exon 1 and 
exon 2 determined by mVista. It shows the intron 1 is about 7k bp. 
81 
AChE is a highly conserved in its catalytic domain, t-peptide, and at cysteine 
residues which form the disulfide bonds at amino acid sequence level. Chicken 
AChE has an extra internal sequence at position 348 of rat AChE, and extra internal 
sequence is also found in teleosts，but at different position, as shown in Figure 3.2. 
As AChE is a highly conserved protein at the structural level, indicated by resolving 
AChE tertiary structure by X-ray diffraction in mammals, torpedo, Drosophila. 
Using the characterized AChE structures as search model, the tertiary structure of 
tnAChE could be predicted by SWISS-MODEL with a certain degree of reliability. 
The extra sequence, 15 residues long, was predicted to form a loop located on the 
molecular surface. This loop forms an a helix secondary structure predicted by using 
secondary structure prediction programs. The secondary structures of the extra 
sequence predicted by different secondary structure prediction program were 
consistent. As SWISS-MODEL uses sequence similarity to predict protein 
structure (Schwede et al 2003), while GOR, HNN and SSpro use neural networks to 
predict structure (Gamier et al 1996; Pollastri et al 2002), and the extra sequence is 
not found in other species AChE, it is more likely to be an a helix on the surface of 
the molecule. It suggested that having an extra sequence, compared to mammalian 
AChE, is probably a characteristic in teleost AChE. An extra internal sequence was 
also reported from zebrafish (Bertrand et al. 2001), through the amino acid sequence 
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is totally different. The functional significance of this extra stretch of 15-amino acid 
domain at the opening of the catalytic cavity in fish AChE is not known. Further 
structural analysis, for example, with the X-ray crystallographic determination, will 
yield more structural information and insight of this loop. 
Glycosylation probably plays an important role in AChE physiological functions. 
The glycosylation pattern of AChE isolated from cerebrum and spinal fluid in 
Alzheimer's patients, was found different from that in normal people (Liao et al 
1992; Saez-Valero et al 2000). In human AChE, three potential glycosylation sites 
were found. Three potential glycosylation sites were also found in mouse and rat 
AChE, with conserved relative position to human AChE. In the tnAChE, there are 
six potential glycosylation sites predicted by SCANPROSITE, which is one 
glycosylation site less than that predicted in zebrafish AChE. Among these six 
putative glycosylation sites in tnAChE, five glycosylation sites are conserved in 
zebrafish, Takifugu rubripes and electrophorus, while three of them are also 
conserved in mammalian AChE, at positions 369, 498 and 573. It suggested that 
AChE in teleosts is more likely to have a higher degree of glycosylation than in 
mammalian AChE. 
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The AChE promoter has been studied in various species. The TATA box or initiator 
is commonly found in promoter, though some genes consist of neither TATA box nor 
initiator. Instead of the TATA box, some genes contain GC rich region, as shown in 
human and mouse AChE (Ben Aziz-Aloya et al. 1993; Ekstrom et al. 1993) and 
housekeeping genes. TBP binds to promoter and initiates transcription. All 
examined AChE promoter regions in different vertebrates show similar GC pattern at 
transcription start sites, regardless of the GC percentage. All GC patterns reach local 
maximum around the transcription start sites. It is interesting to notice that GC 
content of teleost AChE promoter regions was much smaller than the counterpart in 
mammalian; whereas the GC content of mammalian AChE promoter regions is about 
50%. 
There is no common pattern of sequences among vertebrate AChE promoter regions. 
However, in comparison to the sequences of the promoter regions of the two teleosts, 
short conserved sequences were found, although these conserved sequences do not 
seem to harbor any transcription factor binding sites. 
The 5' region of tnAChE exon 1 is different from the zebrafish AChE (Bertrand et al 
2001)，which has a TATA box. Instead of a TATA box, tnAChE exonl is GC-rich, 
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similar to the structures found in human AChE and mouse. In addition, CCAAT 
box was found in tnAChR Several putative E boxes were found by consensus 
sequence. It was reported that intronic E box was important in the transcriptional 
induction of the AChE during myogenic differentiation. Three putative intronic 
E boxes were predicted at 506, 563 and 760 by consensus sequence, and their 
functionality are waited for validation. Tandem repeat is also suggested to be 
important in transcriptional regulation (Schmidt 1999; Jean-Joseph et al 2003; Sinha 
and Siggia 2005; Polak and Domany 2006), and four repeated were predicted and the 
one located between 513 - 542 is the same as in Takifugu rubripes AChE promoter 
region. Seven transcription factor binding sites on ptnAChE.1143 were predicted 
using MATCH™. They are the binding sites of Pax-6, GATA-3, Oct-1, NFY, C/EBP 
and NHF-1. Two binding sites of Pax-6 were predicted. All homologues of Pax-6, 
GATA-3, Oct-1, NFY, C/EBP and NHF-1 in Tetraodon nigroviridis are either 
reported in orthologue prediction in ensembl or blast searched against non-redundant 
protein database in ncbi. The homologues are summarized in Table 3.5. With 
consideration of the conserved non-coding sequence reported among tnAChE and 
Takifugu rubripes AChE using mVista, only binding site of GATA-3 was predicted. 
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Transcription factor human Tetraodon nigroviridis Source 
Oct-1 ENSG00000143190 GSTENG00025967001 Ensembl 
Pax-6 ENSG00000007372 GSTENG00025814001 Ensembl 
HNF-1 ENSG00000135100 GSTENG0002163 0001 Ensembl 
NF-Y XP—707424 CAG07498 Blast 
GATA-S ENSGOOOOO107485 GSTENG00005759001 Ensembl 
C/EBP ENSGOOOOO 172216 GSTENG00023468001 Ensembl 
ENSG00000092067 GSTENG00004553001  
Table 3.5 Homologues of transcription factors predicted using MATCIF^ with 
vertebrate matrix after minimizing false positive 
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NF-Y is an activator, which acts as a reinitiation. HNF-1 is also an activator 
involved in hepatocyte-specific gene expression (Ross et al 1989; Gregori et al 
1993; Bulla and Foumier 1994; Ihara et al. 2003) and cooperates with C/EBP, HNF-4, 
HNF-3. GATA-S was found to possibly play a regulatory role in developing 
chicken brain (Ko and Engel 1993; Kornhauser et al 1994). C/EBP is a 
CAAT/enhancer binding protein. In mouse, it has been reported to critically be 
involved in energy homeostasis and may have a role in regulating the balance 
between cell growth and differentiation (Wang et al 1995; An et al 1996). In the 
case of rat, C/EBP is an activator and is found in many tissues, such as liver, brain, 
adipose, etc (Christy et al 1989; Friedman et al 1989) and expressed only in fully 
differentiated cells, including brain and muscle (Friedman et al 1989). It showed 
significant enhancement of dimerization by Tax (Vinson et al 1993). Pax-6 is 
expressed in different times and at different levels in the central nervous system 
(Okladnova et al 1998; Eagleson et al 2001; Kim et al 2001; Horie et al 2003). 
Spl is a transcriptional factor regulated development (Leone et al 1995). TBP and 
TFIID are important for transcription as they incorporate with PolII (Heller and 
Bengal 1998). CREB is cAMP dependent response element binding protein. It 
was reported XhsiX AChE is regulated in cAMP dependent pathway (Wan el al. 2000; 
Choi et al. 2001; Siow et al. 2002). 
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As the transcription factor binding sites from TRANSFAC are mainly obtained from 
mammalian sequences and minimizing false positive options was obtained by 
mammalian sequences, it may be too stringent to find transcription factor binding 
sites in teleost sequences. Hence, putative transcription factor binding sites on 
ptnAChE.1143 were also identified by a less stringent measure. It was done by setting 
both core and matrix scores to be at least 0.9, followed by identifying them in the 
conserved non-coding sequences. However, as there are not common conserved 
non-coding sequences among all examined sequences, no common transcription 
factor binding sites in the conserved non-coding sequences was found. It may be 
because not all conserved sequences were found. In mVista, it uses global 
alignment algorithm to find conserve sequences. When there is an inversion or 
translation in conserved sequences, the conserved sequences will not be reported. 
This problem can be solved by local alignment in which aligning sequences in 
fragments but not in the whole sequences. Besides, functional transcription factor 
binding sites is possible to be non-overlapped with conserved non-coding sequences. 
Studies on regulation elements have demonstrated that many identified transcription 
factor binding sites are not in conserved sequences (Dermitzakis and Clark 2002; 
Costas et al. 2003; Emberly et al. 2003). In order to have a deeper understanding 
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on the transcription factor binding sites on AChE promoter region, combination of 
transcription factor binding sites and their pattern should be studied. Besides, 
microarray analysis that involves AChE gene expression would also be a useful tool 
to identify the transcription factor binding sites. 
When constructing the promoter-reporter construct, exon 1 and partial intron 1 was 
included due to active regulatory elements found in intron 1 in mouse AChE (Angus, 
et al. 2001). Although GC rich-region and several different transcriptional factor 
binding sites were predicted, no significant promoter activity was found for 
ptnAChE.565 and ptnAChE.1143 in SH-SY5Y and C2C12 cells. There are several 
possible reasons for this finding. Firstly, the 5' region studied may not be long 
enough for it promoter function. Like basal promoter which cannot generate 
significant functionally level of mRNA by itself (Kuras and Struhl 1999; Latchman 
1998; Lee et al. 2000; Lemon and Tjian 2000). Other transcription factors at further 
5' upstream of tnAChE gene or in other regulatory regions such as intron and 
unstranslated region may be needed. Secondly, the promoter may only be 
functional in homologous teleost cell expression system. Although human AChE 
promoter was functional in Xenopus embryos (Ben Aziz-Aloya et al. 1993) and some 
teleost promoters are reported to be heterogeneous functional (Tsai et al 2000), 
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\x\AChE 5' region may be different. It will be better to validate the promoter 
functions in homogenous system. Thirdly, the insignificant change in tnAChE 5' 
region may be due to inclusion of tnAChE exon 1 and partial intron 1. It was 
reported that E-box in intron 1 have played regulatory role in muscle differentiation 
(Angus, et al. 2001). Although three potential E boxes were predicted in the partial 
tnAChE intron, it seemed to be insufficient to drive the transcription� There is 
possible that repressor was within tnAChE exon 1 or intron 1，which represses the 
transcription level and leads to no significant change in promoter activity. In order 
to eliminate the possible influence of exon 1 and partial intron 1, they would be 
deleted and tested for promoter activity. Furthermore, potential translation start 
sites, which are found in the ptnAChE.1143 and ptnAChE.595, also leads to low level of 
promoter activities, and hence no significant change is observed . Six open reading 
frames of ptnAChE.1143 were shown in Appendix 3. Last but not least, the 
insignificant change in promoter activity would be due to low transfection efficiency 
and poor optimization of luciferase assay. 
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Chapter 4 Characterization of tnAChE in Prokaryotic and Eukaryotic Tet-Off 
Inducible Expression System 
4.1 Results 
4.1.1 AChE Expresses in Tetraodon nigroviridis 
Figure 4.1 shows the tissue-dependent tnAChE activity in Tetraodon nigroviridis. It 
was found that the brain, white skeleton muscle and red skeleton muscle express 
relatively higher level of AChE than other tissues examined. Further study 
demonstrated that the cholinesterase activity in Tetraodon nigroviridis brain crude 
extract was strongly inhibited by huperzine, an AChE inhibitor but not by iso-OPMA, 
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Figure 4.1 Tissue distribution of AChE activity in Tetraodon nigroviridis. The 
tissue homogenates from different organs were prepared and assayed for AChE. The 
brain, white skeleton muscle (skw) and red skeleton muscle (skr) exhibited the 
highest level of AChE activity. 
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Figure 4.2 AChE activity of Tetraodon nigroviridis brain crude extract. AChE 
activity was abolished by specific AChE inhibitor huperzine, but not by 
butrylcholinesterase inhibitor iso-OPMA. • : Crude lysate; • : huperzine; • : 
iso-OPMA; X ： iso-OPMA and huperzine. 
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4.1.2 Expression of recombinant tnAChE in Bacterial Expression System 
4.1.2.1 Construction of His-MBP-tnAChEAC/pfflSMAL Construct 
There was a strong and clear band at about 1.8 kb was observed in the agarose gel 
after the PCR amplification. The PCR fragment was gene cleaned, digested with 
restriction enzymes and ligated to pHISMAL at EcoKi and HindUL Positive clones 
were confirmed by restriction digestion using EcoBJ and HindUL 
4.1.2.2 His-MBP-tnAChEAC Expression in E. coli Strains BL21 (DE) and C41 
His-Mal-tnAChEAC was induced in E. coli strains BL2J (DE) and C41 separately 
using 0.1 mM IPTG. His-MBP-tnAChEAC was induced in C41 but not in BL21 
(DE) (Figure 4.3). In C41, His-MBP-tnAChEAC was induced in time-dependent 
manner. The clone 6 was chosen for further studies. Its expression level increased 
from time 0 to 4 hours and leveled up till 24 hours. His-MBP-tnAChEAC was 
mainly found in inclusion bodies (Figure 4.4). Soluble His-MBP-tnAChEAC was 
purified by nickel affinity column and the protein was eluted with 0.5 M imidazole, 
(Figure 4.5). The identity of the purified His-MBP-tnAChEAC was confirmed by 
western blotting. The eluate containing His-MBP-tnAChEAC was failed to be 
cleaved by thrombin, as shown in Figure 4.6. 
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Figure 4.3 
A. His-MBP-tnAChEAC expression of E. coli C41 clones 2, 4, 6 and 8. 
His-MBP-tnAChEAC was induced by 0.1 mM IPTG for 4 hours. C，S and I 
denote crude extract, supernatant and inclusion bodies respectively. 
B. His-MBP-tnAChEAC expression ofE. coli C41 clone 6 at different time points 
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Figure 4.4 His-MBP-tnAChEAC expression in two different E. coli strains. 
A. BL21 (DE) 
B. C4L 
His-MBP-tnAChEAC was induced by 0.1 mM ITPG at log-phase for various hours 
(1.5-7.5 hrs). The numbers indicate the number of hours after induction. N and I 
denote the cells grown in the absence (N) and presence (I) of expression vector. 
Expected size of His-MBP-tnAChEAC is 107.5 kDa. 
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Figure 4.5 Purification of His-MBP-tnAChEAC using nickel affinity 
chromatography. 
A. Coomassie blue staining 
B. Western blotting using anti-His G antibody. 
Lanes M, L, S, F, W, 1, 2, 3 and represents marker, crude extract, supernatant, flow 
through, fractions after washed in 0, 10, 50 and 100 mM imidazole, and finally the 
eluted fraction in 500 mM imidazole respectively. The expected size of 
His-MBP-tnAChEAC is 107.5 kDa. 
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Figure 4.6 Thrombin cleavage of His-MBP-tnAChEAC. His-MPB-tnAChEAC 
was cleaved by l(ig/ml thrombin in PBS (pH 7.4) at 2 5 T h e number indicates 
the number of hours for cleavage. The expected sizes of His-MBP-tnAChEAC and 
His-MBP are 107.5 kDa and 44 kDa respectively. 
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4.1.3 Expression of tnAChEAC in Mammalian Expression System 
4.1.3.1 Construction of tnAChEAC/pTRE2hygo Mammalian Expression Vector 
The tnAChEAC cDNA (1.8 kb) was amplified by RT-PCR and gel purified by gene 
clean. The purified cDNA was then restrictedly digested and ligated to pTRE2hygo at 
Notl and EcoRV. The resulting vector, designated as tnAChEAC/ pTRE2hygro, was 
transformed to competent E. coli. Positive clones were screened by restriction 
digestion of the purified plasmid DNA using Notl and EcoBN, and the gene was 
confirmed by DNA sequencing. 
4.1.3.2 Transient Expression of tnAChEAC 
As shown in Figure 4.7, cell transfected with pTRE2hygro/tnAChEAC resulted in an 
induction of AChE activity by as much as 42-fold compared with those transfected 
with pTRE2hygo only. This indicates that tnAChEAC is functionally expressed in an 
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Figure 4.7 Transient expression of tnAChEAC in Tet-Off CHO cells. The vector 
constructs (2 [ig) was mixed with lipofectamine which were used to transfect the 
Tet-Off CHO cells. Cells were harvested after two days post-transfection. The 
level of AChE activity in tnAChEAC transfected cells was 42-folds higher than that 
of Tet-Off CHO cells transfected with pTRE2hygo vector. Black bars represent 
sample treated with iso-OPMA respectively. 
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4.1.3.3 Establishment of Tet-Off CHO Cells Stably Expressing the Inducible 
tnAChEAC. 
After transient transfection, the cells were further cultured in the presence of 
hygromycin for the selection of stably transfected clonal cells. After several weeks of 
clonal selection and expansion, thirty clones were picked and screened for expression 
of AChE. The result of the screening is shown in Figure 4. 8 A. The clones with 
number of 3, 14, 23, 24, 29 and 30 were chosen for further characterization because 
they consistently showed higher induction of AChE activity (Figure 4.8.B). Finally, 
the clones 23 and 24 were further used for scale-up of cell cultures and purification 
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Figure 4.8 Screening of different clones of tnAChEAC. 
A. Preliminary screening of AChE activity in 30 different clones. 
B. Screening of clones number 3，14, 23, 24 29 and 30 for their induced AChE 
activity 
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4.1.3.4 Characterization of Tet-OfFtnAChEAC Stably Transfected Cell Clones 
Both clones 23 and 24 expressed AChE significantly over the control in an inducible 
manners and its level of activity was time dependent. Both of the clonal cell lines 
exhibited similar inducible expression pattern, as shown in Figure 4.9 and Figure 
4.10. Expression of tnAChEAC was significantly increased after removal of 
doxycycline and AChE activity reached the highest level at 8 hours after induction 
and then reduced sharply after 12 hours and continued to decrease for the next 12 
hours. In general, clone 23 expressed higher level of functional tnAChEAC than 
clone 24. Clone 23 was therefore chosen for further tnAChEAC purification and 
characterization. 
4.1.3.5 Effect of Over Expressed tnAChEAC on Cell Viability 
Cell viability was determined by MTT assay. As shown in Figure 4.11, it was 
found that the cells clones (clone 23 and 24) over expressed with tnAChEAC 
remained viable and proliferated more than the control cultures. It was therefore 
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Figure 4.9 Time-dependent induction of tnAChEAC clone 23 
A. Time-dependent increase in AChE activity of clone 23. AChE activity was 
measured by the Ellman's method. Asterisks denote p < 0.05 when it is 
compared with the non-induced control. STS denotes Tet-Off CHO cells 
treated with 1 |iM staurosporine for 18 hours. Black and grey bars represent 
sample treated with iso-OPMA and huperzine respectively. 
B. Western blotting of AChE and GAPDH of clone 23 at different times. 10 fig of 
total protein was loaded in each lane. 
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Figure 4.10 Induction of tnAChEAC clone 24 
A. Time-dependent increase in AChE activity of clone 24. It was measured by the 
Ellman's method. Asterisks denote p < 0.05 when it is compared with the 
non-induced control. STS denotes Tet-Off CHO cells treated with 1 ^M 
staurosporine for 18 hours. Black and grey bars represent sample treated with 
iso-OPMA and huperzine respectively. 
B. Western blotting of AChE and GAPDH of clone 24 at different times. 10 ^g of 
total protein was loaded in each lane. 
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Figure 4.11 Effect of tnAChEAC induction on cell viability. 
The tnAChEAC stably transfected CHO cell clone 23 and 24 were induced by 
removal ofDox for 2-24 hours and then measured the cell viability by the MTT assay. 
CHO treated with staurosporine was included as positive control of apoptosis. 
Tet-Off CHO and STS denote Tet-Off CHO and Tet-Off CHO treated with 1 i^M 
staurosporine respectively. Black and grey bars represent clone 23 and clone 24 
respectively. 
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4.1.3.6 Partial Purification of tnAChEAC from Stably Transfected Cells 
In order to enrich the functional tnACHEAC protein, the cell lysates were 
precipitated by saturation of ammonium sulfate. As shown in Figure 4.12, highest 
AChE activity was found in protein precipitated from 40% to 60% ammonium 
sulfate saturation, followed by 60% - 80% saturation. Hence, tnAChEAC was 
precipitated from 40% to 80% saturation of ammonium sulfate. 
Twenty 0.9-ml fractions in HPLC-Gel were collected and the AChE activity of 
different fractions was measured which was shown in Figure 4.13. A single peak 
was obtained between fractions 8 and 10, whereas fraction 9 showed the highest 
AChE activity. Figure 4.14 shows AChE activity in crude extract of tnAChEAC 
clone 23, protein precipitated by ammonium sulfate and HPLC-Gel fraction 9. 
AChE activity was enriched during partially purification. Figure 4.15 shows AChE 
protein amount was enriched in the fraction 9. The final enzymatic yield of 
tnAChEAC is about 86% with purification factor 14.5 (Table 4.1). 
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Figure 4.12 Purification profile of tnAChEAC using ammonium sulfate. AChE 
activity dropped sharply from between 40% and 80% ammonium sulfate. 
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Figure 4.13 AChE activities of different fractions obtained from HPLC-Gel using 
Superdex 75 10/300 GL after injection. A single peak located at fraction 9 which 
shows it contained highest AChE activity. Vo denotes the void volume. The arrow 
indicated the elution of dimeric orange florescent protein (OFP2) with about 61 kDa. 
Optimum separation range of the column is 3k - 70k Da. 
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Figure 4.14 AChE activities of crude extract, protein precipitated between 40% and 
80% saturation of AS and HPLC-Gel fraction 9 of tnAChEAC clone 23. Increase in 
AChE activity was observed during the partially purification. Black and grey bars 
represent sample treated with iso-OPMA and huperzine respectively. 
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Figure 4.15 tnAChEAC after partial purification. 9, 11 and L denote fraction 9, 
fraction 11 after HPLC-gel filtration and crude lysate of clone 23 after induction 
respectively. The tnAChEAC was enriched after HPLC-gel filtration as indicated 
by arrow. The expected size of tnAChEAC is 63.4 kDa. 
Total AChE Total protein AChE % y i e l d P u r i f i c a t i o n 
Sample . . , � . . ^ 
activity ( / /g) activity factor 
Lysate 160.1778 8374.87 0.019126 100 1 
40%-80% 
148.92 2369.78 0.062841 93.0 3.29 
precipitate 
Fraction 9 139.2 539.30 0.25811 86.9 13.5 — 
Table 4.1 Partial purification of tnAChEAC using ammonium sulfate precipitation 
and HPLC-Gel filtration. Clone 23 of tnAChEAC Tet-Off CHO cells were induced 
by 8 hours and harvested for the preparation of cell lysates. TnAChEAC was partial 
purified by ammonium sulfate and HPLC-Gel filtration. The 40%-80% 
precipitation and fraction 9 denoted the ammonium sulfate precipitation between 
40%-80% and fraction 9 of HPLC-Gel filtration. 
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4.1.3.7 TnAChE and tnAChEAC in Different pH Values 
Figure 4.16 shows the comparison of tnAChE enzyme activity from Tetraodon 
nigroviridis brain and that of tnAChEAC from isolated from inducible tnAChEAC 
Tet-Off CHO clones 23 and 24. In contrast to the tnAChE from Tetraodon 
nigroviridis brain which showed optimum AChE activity at pH 8. The tnAChEAC 
from Tet-Off inducible CHO cells showed optimum AChE activity at pH 7. 
4.1.3.8 Kinetic Study of tnAChEAC 
As shown in Figure 4.17, the AChE exhibited a classical Michealis-Menten kinetics 
with an estimated Km value to acetylthiocholine at 280.9 土 28.7 |iM by fitting to 
Michaelis-Menten equation. 
4.1.3.9 Inhibition of AChE Activity of Partial Purified tnAChEAC by Huperzine 
Figure 4.18 shows that the inhibitory effect of huperzine on the tnAChEAC in 
fraction 9 which was dosage dependent. When 1 mM huperzine was used, the 
inhibitory effect was over 80%. The IC50 of huperzine was estimated to be 0.2827 
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Figure 4.16 AChE activities of Tetraodon nigroviridis brain and tnAChEAC Tet-Off 
CHO clones 23 and 24 crude extract in different pH values. All crude extracts 
shows a bell-shape in AChE activity along pH 4 to pH 10. Crude extract of brain 
shows optimal AChE activity at pH 8, whereas clones 23 and 24 show maximal 
AChE activity at pH 7. Black, grey and white bars represent clone 23, clone 24 and 
Tetraodon nigroviridis brain lysate respectively. 
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Figure 4.17 Kinetic study of tnAChEAC. The HPLC-gel filtration purified AChE 
activity was assayed at various concentrations of acetylthiocholine. By fitting 
Michaelis-Menten equation using SigmaPlot (y=9.7116*x/(280.9+x)), Km value to 
acetylthiocholine is estimated to be 2 8 0 . 9 士 28.7 | J M . 
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Figure 4.18 Inhibitory effect of huperzine on tnAChEAC. 1 i^l fraction 9 (0.045 |ig 
protein) was used in 200 [d reaction. By fitting Michaelis-Menten equation using 
SigmaPlot (y=1.1145*x/(0.3474+x)), the IC50 is 0.2827 mM. It shows that 
huperzine inhibited over 80% AChE activity in tnAChEAC at 1 mM 
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4.2 Discussion 
3.2.1 Bacterial Expression System 
AChE has been the important enzyme that has been extensively studied for many 
decades. It was first characterized by its esterase activity on the rapid hydrolysis of 
acetylcholine, a cholinergic neurotransmitter (Stein and Koshland 1953). Because 
of its important role in cholinergic transmission, it was considered a major inhibitory 
targets as bio-weapons (Soreq and Seidman 2001). Besides, AChE also plays an 
important role in the pathogenesis of Alzheimer's disease (Greenblatt et al 2003; 
Inestrosa et al 2004; Small 2004). Drugs that are currently available for Alzheimer's 
disease patients are mostly AChE inhibitors (Ogane et al. 1992; Lane et al. 2004; 
Small 2005). AChE was first purified from Torpedo California, due to its abundant 
expression in the electron organ (Taylor et al 1974). Over the years, scientists have 
tried to develop methods to express AChE in large quantities for functional and 
structural analysis. Due to its molecular complexity, functional recombinant AChE 
has been difficult to obtain. Nevertheless, recombinant AChE has been expressed in 
different host systems, for example, in bacteria, yeast, insect and mammalian cells 
(Sussman et al. 1993; Heim et al 1998; Bertrand et al 2001). The general problem 
of recombinant AChE production in bacterial expression system is that in many 
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occasions the produced enzyme was always expressed in misfolded protein in the 
form of inclusion bodies. Therefore, the procedure for unfolding and refolding is 
necessary in order to obtain active AChE. However, this procedure resulted in the 
low yield production (Fischer et al 1995; Heim et al 1998). In this study, an effort 
has been made to improve the solubility and generation of functional AChE from the 
cDNA of tnAChEAC. The gene coding for the active enzyme was fused 
downstream to a gene of histidine-tagged maltose binding protein to generate 
His-MBP-tnAChEAC in order to improve solubility of recombinant proteins. MBP 
was reported to improve solubility of fused protein. MBP is composed of a 
hydrophobic H-domain, short positively charged N-domain and C-domain with 
Ala-X-Ala box. Ala-X-Ala box is recognized and cleaved by signal peptidase I. 
MBP has a signal sequence that promotes secretion of recombinant protein from 
cytoplasm to periplasm (Choi and Lee 2004) . Generally speaking, proteins are first 
synthesized as premature protein in the cytoplasm and then secreted to outer 
membrane or periplasmic space with an aid of signal sequence. The secretion of 
protein commonly employs type II protein secretion systems. It involves a two-step 
process in which a premature protein with a signal sequence is exported to the 
periplasmic space through Sec pathway and become mature. Secretary production 
of recombinant proteins has several advantages compared to cytosolic production. 
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Firstly, less protease activity was suggested in the periplasmic space than in the 
cytoplasm. Secondly, the purification is simpler because of fewer contaminating 
proteins in the periplasm. Besides, the periplasmic space provides a more oxidative 
environment that the cytoplasm, winch facilitated the correct formation of disulfide 
bonds. However, the efficiency of protein secretion varies depending on the host 
strain, signal sequence, and the type of protein to be secreted. In addition, the 
C-terminal region of tnAChE (582-620), the so-called t-peptide, was deleted to 
prevent oligomerization and aggregation among tnAChE. In order to produce 
tnAChEAC without glycosylation in large scale, the first attempt was to express the 
protein in E.. coli. The bacterial strain C41 instead of the routinely used BL21 (DE), 
was used as host for His-MBP-tnAChEAC expression because of no observable 
His-MBP-tnAChEAC expression in BL21(DE). It agreed with previously report 
that BL21(DE) failed to express some globular and membrane proteins (Miroux and 
Walker 1996). The present results indicated that His-MBP-tnAChEAC was 
predominantly expressed as inclusion bodies, similar to the data reported in previous 
study (Fischer et al 1995). It is therefore concluded that His-MBP did not facilitate 
protein solubility in His-MBP-tnAChEAC. Nevertheless, there is indication that 
small amount of His-MBP-tnAChEAC was produced which could be purified using 
nickel affinity chorography. The affinity purified AChE show multiple bands of 
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his-tagged protein as demonstrated by their immunoreactivity towards anit-His G 
antibody (Figure 4.6). These bands could be explained by non-specific proteins that 
bound to nickel affinity chorography. The most possible explanation however could 
be due to degradation of His-MBP-tnAChEAC during the induction of cell culture. 
Although the strategy in using the His-MBP improves the solubility in small quantity, 
there is still problematic as the His-MBP proved difficult to be removed because the 
fusion protein was unable to be cleaved by thrombin. The problem probably lies on 
the fact his-MBP-tnAChEAC may form micelle-like soluble aggregates which 
prevent thrombin to access the cleavage sites. 
3.2.2 Expression of tnAChE in Mammalian System 
In an attempt to search for alternative expression system to prepare enzymatically 
active tnAChE, an inducible mammalian expression called the Tet-Off system has 
been characterized in this study. In this cell inducible expression system, the 
plasmid which was stably transfected in mammalian cells drives the expression of a 
bacterial transactivating protein tTA in response to antibiotic tetracycline induction. 
This transactivator tTA binds to a modified CMV promoter to activate the target gene 
transcription of the transfected plasmid harboring the target gene sequence 
downstream of the CMV promoter. By this approach, we have prepared 30 clones 
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that were stably transfected with tnAChEAC/pTRE2hygo. Among them, two clones, 
designated as clone 23 and clone 24, were further characterized. Finally the clone 
23 was chosen because of its high AChE activity after induction. 
Using the cell inducible expression offers a better approach to characterize 
recombinant protein as the background of enzyme in control cells shows no or little 
enzyme activity. There has been a report suggesting that an increase in AChE 
expression in cells is associated with the induction of apoptosis (Zhang et al 2002). 
In order to investigate whether the increase in AChE activity in the induced cultures 
was due to apoptosis, Tet-Off CHO cells treated with 1 |jM staurosporine for 18 
hours was used as control. Staurosporine has been used as an initiator of apoptosis 
is many different cell lines for a long time (Krohn et al 1998; Johansson et al 2003; 
Zhang et al. 2003; Zhang et al 2004). It was reported that staurosporine not only 
activates Bax and mitochondrial caspase-dependent apoptotic pathways, but also 
induced apoptosis by caspase-independent pathways in melanoma (Zhang et al. 
2004). Staurosporine is used here as an agent to induce apoptosis. As shown in 
Figures 4.10Aand 4.11A, AChE activity is somewhat increased during apoptosis, the 
increase is much lower compared to those AChE activity levels found in the 
inducible cultures. AChE activity in the inducible Tet-Off cell showed 15-folds and 
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14-folds increase after 8 hours of induction compared to control Tet-Off CHO cells 
treated with staurosporine. Both clones 23 and 24 showed slightly increase in 
AChE activity in the non-induced cultures which could be due to leaky expression of 
tnAChEAC. In this study, we failed to confirm that over-expression of AChE lead 
to apoptosis and cell death. On the contrary, we found that over expression of 
tnAChEAC showed a proliferation effect because the cell viability increased after 
induction (Figure 4.12). The increase in cell viability could due to removal of 
doxycycline, which is cytotoxic to cells. The finding is inconsistent with the result 
of a previous study on AChE which indicated that AChE is a cell death mediator 
(Zhang et al 2002). The possible reason to account for such difference is t-peptide. 
T-peptide is a 40 residue fragment at C terminus of AChE T form. It is highly 
conserved among vertebrate, as shown in Figure 3.2. It processes a series of seven 
conserved aromatics residues and forms an amphiphilic a helix. It allows the 
formation of homo-oligomer and heteromic associations with the anchoring proteins, 
for example, ColQ (Ohno et al 1998) and PRiMA (Perrier et al 2002; Perrier et al 
2003). An AChE peptide derived from t-peptide (AEFHHRWSSYMVHK) was 
found to be cytotoxic and induced neuronal cell death (Day and Greenfield 2003). 
Both the activities of AChE prepared from the crude extract of Tetraodon 
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nigroviridis brain and lysates of the induced cell cultures showed pH dependency. 
The optimal pH for AChE activity is around pH 6-8. However, there is a slight 
difference between the crude extract from Tetraodon nigroviridis brain and the 
expressed AChE from cell cultures. The recombinant AChE has a pH optimal slightly 
acidic than that found in brain lysates which is optimal at pH 8. The difference may 
be due to different glycosylation of tnAChE in native tnAChE and recombinant 
tnAChEAC. Although the recombinant tnAChEAC and native tnAChE is different 
from their C-terminus, it is unlikely that the deletion of t-peptide contributes the 
difference, as it was AChE activity is contributed by the catalytic domain, which is 
common in AChE-R form, AChE-T form and AChE-H form, though they have 
distinct C-termini (Sternfeld et al 1998). 
In Tet-Off system, both AChE activities of tnAChEAC in clone 23 and 24 peaked at 
8 hours after induction and then decreased in activity gradually. The decrease in 
activity could be due to protein degradation or due to the secretion of cellular 
enzyme to the culture medium. In order to confirm the secretion of AChE, the 
medium after induction has been collected and the proteins in culture medium was 
enriched by ammonium sulfate precipitation. However, there is no evidence that 
secretable AChE was increased as there is no detectable AChE present in the culture 
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media by western blotting (data not shown). Therefore, it is concluded that 
expression of recombinant AChE in mammalian cells is very unstable and prompt to 
degradation in these cells. 
Characterization of the AChE prepared from the cell lysates with high performance 
gel filtration chromatography demonstrated a single peak of AChE activity at MW 
larger than 61 KDa which indicates that there is only one molecular form of AChE 
expressed in tnAChEAC Tet-Off CHO cells, which is a monomer. This enzyme was 
partially purified by ammonium sulfate precipitation (40-80% saturation) which 
resulted in an enrichment of enzyme activity in the preparation. In conclusion, the 
use of an inducible stably AChE transfected clonal cell line may prove to be a viable 
alternative approach to prepare enzymatically active AChE for kinetic and structural 
analysis. 
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Chapter 5 General Discussion 
4.1 Summaries 
As Tetraodon nigroviridis has a compact genome, its intergenomic region is shorter 
that in mammalian, which suggests regulatory elements in the promoter region would 
be more condensed and clustered together. It would serve as an ideal model to find 
functional regulatory elements for transcription and elucidate the transcriptional 
regulation for AChE in teleost. AChE cDNA from Tetraodon nigroviridis brain was 
isolated and characterized. It has nine putative exons with consensus splicing 
motifs, and the full coding sequence of tnAChE encodes for a protein of 620 amino 
acid residues. Transient expression of tnAChE cDNA showed an increase in AChE 
activity, thus demonstrating the functional property of the enzyme. Sequence 
analysis of the tnAChE protein indicates that the enzyme has a highly conserved 
catalytic triads and C-terminal t peptide. It shares over 70% similarity to the AChEs 
of vertebrates including human, mouse and rat. It consists of six potential 
glycosylation sites，in which five out of six was conserved in teleosts. The tnAChE 
is similar to zebrafish AChE, in which zebrafish AChE contains an extra internal 
sequence compared with the mammalian AChEs (Figure 2.2). This stretch of amino 
acid sequence, which is corresponding to tnAChE (443-457), was predicted to fold as 
an a helix in tnAChE. By contrast, a random loop was predicted in similar sequence 
124 
domain of zebrafish AChE. Both of these extra sequences are predicted to locate on 
the protein surface. 
In the analysis of XnAChE promoter region, CG rich regions and CAAT box were 
found with several putative transcription factor binding sites. GATA-3 was 
predicted in the conserved non-coding sequences of tnAChE and Takifugu rubripes. 
The GC pattern of AChE promoter regions around the transcription start sites is 
similar, which contains a peak in GC pattern, through the sequences are divergent . . 
For tnAChE protein expression, His-MBP-tnAChEAC was expressed in E. coli as 
inclusion bodies. Little amount of soluble His-MBP-tnAChEAC was produced in 
supernatant, and it could not be cleaved by thrombin after partial purification using 
nickel affinity chromatography. The Tet-Off mammalian system expression was 
found to be more successful to produce active recombinant tnAChE. In this cell 
expression system, the level of tnAChEAC, measured by activity, reached its 
maximum eight hours after induction. Over-expression of AChE in these cells 
showed no toxic effect and signs of cell death. This result contradicts with the recent 
proposal of an association of AChE with apoptosis (Zhang et al 2002). The 
tnAChEAC was partially purified to 13.5-fold of the original crude extract. The Km 
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of tnAChEAC to acetylthiocholine is estimated to be 280.9 士 28.7 pM, which is 
similar to the data obtained from zebrafish AChE (Bertrand et al 2001). 
4.2 Further work 
It was reported that intronic region of AChE plays a regulatory role in transcription 
(Chan et al 1999; Angus et al 2001) in mammalian AChE genes. In the teleost, 
there is little information whether this intron plays a similar role in Tetraodon 
nigroviridis. Further upstream 5’ sequence of tnAChE is also necessary to be 
examined in order to validate and characterize the promoter region of tnAChE. A 
more systematic comparison approach is needed to examine the genomic structure 
and promoter regions of AChE to elucidate the difference among species, which may 
provide insight for evolutionary of promoter and genomic structure. Furthermore, 
although the structure was predicted, the real structure of AChE will not be clear 
until the x-ray crystallography or NMR of this enzyme is obtained. 
An attempt to express this protein in bacteria was not very satisfactory. Using the 
inducible cell expression system, it appears that the tnAChE is functionally 
expressed. The kinetics parameters and pH sensitivity are consistent with the values 
from other species. This study will pave the way for large-scale purification of 
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tnAChE for structural analysis. 
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Appendix 1 internet software or database used in this project 
Database 




• http://www. genoscope. ens. fr/externe/tetranew/ 
Software 
• EMBOSS: http://bioinfo.hku.hk 
• Clustalx: http://www.ebi.ac.uk/clustalw/index.html 
• MATCH™ and TRANSPLORER: http://www.gene-regulation.com/index.html 
• SWISS-MODEL: http://swissmodel.expasy.org/ 
• mVista: http://genome.lbl.gov/vista/mvista/submit.shtml 
• repeatfinder: http://www.genet, sickkids.on.ca/~ali/repeatfmder.html 
• perl: http://www.activeperl.org 
• deepview: http://swissmodel.expasy.org/spdbv/ 
• blast: http://www.ncbi.nlm.nih.gov/blast 
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Appendix 2 tnAChE mRNA sequence 







































Appendix 3 ptnAChE.1143 sequence 




































Appendix 3 Six open reading frame translation of ptnAChE.1143 










FWGPP1111LTIV 丨1111丨 T11SIKFKLAATGLQK*SITIISIGVFLNC*GYFLEI TEAK 
SNAEKSKDIFTFLIDR*ICVCLSVCFKKEMECHCDHMFCKGN 
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